Drug delivery device safety system
By designing the structure of the housing, plunger rod and thumb pad in the drug delivery device, the state transition is achieved to prevent accidental acupuncture and premature locking, the safety concerns in the prior art are solved, ensuring correct and safe Drug delivery.
Patent Information
- Application Number
- CN202380029609.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-01-20
- Filing Date
- 2023-01-25
- Publication Date
- 2024-11-08
AI Technical Summary
There are safety concerns during use of existing drug delivery devices, including premature discharge of fluid, accidental acupuncture before and after injection, premature latching before dose ends, especially the accidental removal of passive safety devices by the user. The device may result in the inability to complete the dose or accidental acupuncture.
A drug delivery device is designed, including a housing, a plunger rod and a thumb pad. Through the structural design between the housing and the thumb pad, the plunger rod can be freely moved and locked in different states, ensuring that it is before injection. , period and after use correctly and safely to prevent accidental acupuncture and premature closure. Specific designs include engagement and separation mechanisms between the housing and the thumb pad, using auditory feedback and mechanical structure to prevent premature needle puncture and latching.
It effectively prevents safety issues in the drug delivery device during use, ensures correct delivery of drugs, avoids unexpected acupuncture and premature latching, and improves the safety experience of users.
Smart Images

Figure CN118922218A_ABST
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority to U.S. Provisional Patent Application Nos. 63 / 302,989 filed on January 25, 2022, 63 / 305,763 filed on February 2, 2022, and 63 / 480,904 filed on January 20, 2023, all of which are incorporated herein by reference. Technical Field
[0002] The present disclosure relates to drug delivery device (eg, prefilled syringe) safety systems and uses thereof. Background Art
[0003] Drug delivery devices (e.g., pre-filled syringes, auto-injectors or other suitable drug delivery devices) are typically used to deliver fluid drug substances. Various safety concerns may occur before, during and after using the drug delivery device. In order to address these concerns, traditional safety devices have been developed. Conventional safety devices may include active safety mechanisms. In such devices, users need to actively perform specific actions to trigger the safety mechanism. Users may be difficult to properly activate the safety mechanism while properly utilizing the drug delivery device to inject drug substances into themselves or other people. In contrast to these active safety devices, passive safety devices have been developed, in which users do not need to perform any additional and / or separate actions to trigger the safety mechanism during and / or after using the drug delivery device.
[0004] In a passive safety system, there may still be concerns about user safety and proper use of the drug delivery device. For example, there may be premature discharge of fluid, accidental needle sticks before and / or after injection, and / or premature lockout before end of dose. The passive safety mechanism should be constructed for correct and safe use before, during, and after injection. Summary of the invention
[0005] The present disclosure describes a drug delivery device, the device comprising a housing; a product container disposed in the housing; a plunger rod partially disposed within the product container; and a thumb pad configured to receive a portion of the plunger rod, wherein the thumb pad and the plunger rod are configured to transition from a first state to a second state, wherein in the first state the plunger rod is prevented from moving in a proximal direction, and in the second state the plunger rod is free to move in the proximal direction.
[0006] Various embodiments of the device may include one or more of the following aspects. The thumb pad may include an extension that protrudes distally from the thumb pad. The housing may include a shoulder, wherein in the first state, the shoulder protrudes radially inward and prevents movement of the product container. In the second state, the extension of the thumb pad is configured to deflect the shoulder radially outward to allow the product container to move in a proximal direction. The product container and a needle attached to the distal end of the product container can be retracted into the housing in a proximal direction so that the needle is located proximal to the distal end of the housing. The distance that the product container is retracted proximally into the housing in the second state can be substantially equal to the length that the needle extends distally from the housing in the first state. The proximal portion of the plunger rod may include a flange, and the thumb pad may include a recess configured to receive the flange. The plunger rod may abut the inner distal surface of the thumb pad in the second state. When a portion of the plunger rod abuts the inner distal surface of the thumb pad in the second state, an audible feedback may be generated. The housing may include a surface configured to deflect a portion of the thumb pad in an outward direction to release the proximal portion of the plunger rod when transitioning to the second state. The housing may include a cutout configured to engage a portion of the thumb pad to couple the thumb pad to the housing in the second state. The plunger rod may include a first portion and a second portion, the diameter of the first portion being greater than the diameter of the second portion, such that in the first state, the first portion is proximal to the second portion, and in the second state, the second portion collapses (contracts) into the first portion. The device may include a rotator configured to be positioned proximal to the proximal end of the product container in the first state and configured to surround the proximal end of the product container in the second state. The plunger rod may include a first portion and a second portion, the distal end of the second portion being coupled to the proximal end of the first portion, and the housing may include a proximal extension, wherein in the first state, the proximal extension abuts the distal end of the first portion, thereby preventing the product container from moving proximally away from the housing. In a second state, the proximal extension can be deflected away from the distal end of the first portion, thereby allowing the product container to move proximally away from the housing and into the thumb pad. The proximal end of the housing can include a rear cap configured to surround the proximal end of the product container.
[0007] The present disclosure also describes a drug delivery device, which includes: a housing; a product container disposed in the housing, and a needle extending from a distal end of the product container; a plunger rod for dispensing a product from the product container, the plunger rod including a first recess at a distal portion of the plunger rod and a second recess at a proximal portion of the plunger rod; a blocking member at the proximal end of the housing, wherein the plunger rod is slidably received within the blocking member, and wherein the blocking member includes a deflectable arm; and a needle cover at least partially disposed in the housing.
[0008] Various embodiments of the device may include one or more of the following aspects. The device may be configured to transition from a first state, in which the distal end of the needle cover abuts the deflectable arm and the deflectable arm is aligned with the first recess, to a second state, a third state, in which the deflectable arm is radially deflected outward, and in which the deflectable arm is aligned with the second recess and the distal end of the needle cover is located proximal to the deflectable arm. The second recess may have a smaller diameter than the first recess. The housing may include a boss portion, which is used to abut a portion of the needle cover to prevent the needle cover from moving proximally into the housing. In the first state, the needle cover may extend distally of the housing to cover the needle. In the second state, the proximal end of the needle cover may abut a distal portion of the blocking member. In the first state, the deflectable arm may limit the movement of the plunger rod, and wherein in the second state, the deflected deflectable arm may allow the movement of the plunger rod. The device may include an inner rod configured to be fixed within the plunger rod. The inner rod may include a distal block configured to abut a portion of the plunger rod, thereby preventing the plunger rod from moving in a distal direction. The distal end of the plunger rod includes a deflectable arm configured to abut a portion of the inner rod, thereby preventing the plunger rod from moving in a distal direction. The plunger rod may include a flexible section, such that in a first state, the distal block prevents the flexible section from compressing, and in a second state, the distal block can move away from the flexible section to allow the flexible section to compress. The housing may include a finger flange and a button mechanism, wherein the button mechanism is configured to abut a portion of the plunger rod in a first state and deflect away from the plunger rod in a second state.
[0009] The present disclosure describes a drug delivery device, the device comprising: a housing; a plunger rod; a needle cover at least partially disposed within the housing; and a rotating component having a track extending along an outer surface of the rotating component, wherein a portion of the plunger rod extends through a central region of the rotating component, wherein the rotating component is located radially inward of a proximal portion of the needle cover, and wherein a protrusion of the needle cover engages the track of the rotating component and is configured to move along the track of the rotating component when the device transitions from a first state to a second state and to a third state.
[0010] Various embodiments of the device may include one or more of the following aspects. The device may also include a product container for containing a liquid drug product; and a stopper disposed within the product container, wherein distal movement of the plunger rod causes the stopper to move distally, and wherein, in a first state, the protrusion engages a first end of a track and distal movement of the plunger rod is restricted. In a second state, the protrusion may engage a middle portion of the track such that distal movement of the plunger rod is permitted, and the needle cover may be positioned further proximally within the housing relative to the position of the needle cover in the first state. In a third state, the protrusion may engage a second end of the track, and the needle cover may be further distally located within the housing relative to the position of the needle cover in the second state to extend from the distal end of the housing. In the third state, the needle cover may be further distally located within the housing relative to the position of the needle cover in the first state, wherein the needle cover extends from the distal end of the housing in the first state and in the third state.
[0011] The present disclosure also describes a drug delivery device, comprising: a housing, the housing comprising a deflectable tab; a syringe arranged in the housing; a plunger rod, the plunger rod comprising a stopper for dispensing a product contained in the syringe; a needle cover, the needle cover being at least partially disposed in the housing, the needle cover comprising a recess; and a ring comprising a boss portion, the ring being positioned around the proximal end of the syringe, wherein the device is configured to transition between a first state, a second state, and a third state, wherein in the second state, the needle cover is further proximally located within the housing compared to the first state and the third state, the proximal end of the needle cover is configured to push the deflectable tab of the housing outward, and the recess of the needle cover engages with the boss portion of the ring.
[0012] Various embodiments of the device may include one or more of the following aspects. In the third state, the needle cover and the ring may be located distally of the deflectable tab, and the deflectable tab may limit movement of the needle cover in the proximal direction. In the first state, the needle cover may be located distally of the ring.
[0013] The present disclosure describes a drug delivery device, which includes a housing; a product container arranged in the housing; and a plunger rod partially disposed inside the product container, the plunger rod including a first portion and a second portion, wherein the first portion is configured to receive the second portion, wherein the first portion and the second portion of the plunger rod are configured to transition from a first state to a second state, wherein in the first state, the second portion of the plunger rod is prevented from moving in a proximal direction, and in the second state, the second portion of the plunger rod is free to move in a proximal direction.
[0014] Various embodiments of the device may include one or more of the following aspects. The portion may include a thumb pad. The thumb pad may include a recess configured to receive the second portion of the plunger rod. In the second state, the second portion of the plunger rod may be moved in a proximal direction into the first portion of the plunger rod. The plunger rod may include a flexible portion. The second portion of the plunger rod may be removably coupled to the first portion of the plunger rod. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various examples and, together with the description, serve to explain the principles of the disclosed examples and embodiments.
[0016] Aspects of the present disclosure may be implemented in conjunction with the embodiments shown in the accompanying drawings. These drawings show different aspects of the present disclosure. Where appropriate, reference numerals showing similar structures, components, materials and / or elements in different drawings are similarly labeled. It should be understood that various combinations of structures, components and / or elements are contemplated in addition to those specifically shown, and various combinations of structures, components and / or elements are within the scope of the present disclosure.
[0017] In addition, many embodiments are described and illustrated herein. The present disclosure is not limited to any single aspect or embodiment thereof, nor is it limited to any combination and / or arrangement of these aspects and / or embodiments. In addition, each aspect of the present disclosure and / or its embodiments may be used alone or in combination with one or more of the other aspects of the present disclosure and / or its embodiments. For the sake of brevity, certain arrangements and combinations are not discussed and / or illustrated separately herein. It is noteworthy that embodiments or implementations described herein as "exemplary" should not be interpreted as, for example, being superior to other embodiments or implementations; on the contrary, it is intended to reflect or indicate that (one or more) embodiments are (one or more) "example" embodiments.
[0018] Figure 1A-1B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0019] Figures 2A-2F Depicted Figure 1A-1B Additional aspects and embodiments of an exemplary security device.
[0020] Figure 3A-3B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0021] Figures 4A-4D Depicted Figure 3A-3B Additional aspects and embodiments of an exemplary security device.
[0022] Figures 5A-5D Depicted Figure 3A-3B Additional aspects and embodiments of an exemplary security device.
[0023] Figure 6A-6B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0024] Figures 7A-7F Depicted Figure 6A-6B Additional aspects and embodiments of an exemplary security device.
[0025] Figures 8A-8B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0026] Figures 9A-9D Depicted Figures 8A-8B Additional aspects and embodiments of an exemplary security device.
[0027] Figures 10A-10B Depicted Figures 8A-8B Additional aspects and embodiments of an exemplary security device.
[0028] Fig.11 An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0029] Figures 12A-12C Depicted Fig.11 Additional aspects and embodiments of an exemplary security device.
[0030] Figures 13A-13B Depicted Fig.11 Additional aspects and embodiments of an exemplary security device.
[0031] Figures 14A-14C An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0032] Figures 15A-15D Depicted Figures 14A-14C Additional aspects and embodiments of an exemplary security device.
[0033] Figures 16A-16B Depicted Figures 14A-14C Additional aspects and embodiments of an exemplary security device.
[0034] Figures 17A-17G An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0035] Figures 18A-18B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0036] Figures 19A-19B Depicted Figures 18A-18B Additional aspects and embodiments of an exemplary security device.
[0037] Figures 20A-20C Depicted Figures 18A-18B Additional aspects and embodiments of an exemplary security device.
[0038] Figures 21A-21C Depicted Figures 18A-18B Additional aspects and embodiments of an exemplary security device.
[0039] Figures 22A-22B Additional aspects and components of exemplary security devices according to embodiments of the present disclosure are depicted.
[0040] Figures 23A-23B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0041] Figures 24A-24C An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0042] Fig.25 An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0043] Figures 26A-26B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0044] Figures 27A-27B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0045] Figures 28A-28B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0046] Figures 29A-29B An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0047] Figures 30A-30DAn exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0048] Fig.31 An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0049] Figures 32A-32F An exemplary security device and components thereof are depicted in accordance with embodiments of the present disclosure.
[0050] When used herein, the terms "include", "comprises" or any other variants thereof are intended to cover non-exclusive inclusion, so that the process, method, article or device including a series of elements includes not only those elements, but also other elements that are not explicitly listed or inherent to such processes, methods, articles or devices. The term "or" is inclusive and is intended to represent that the process, method, product or device including the list of each element may include a combination of elements or all elements. The term "exemplary" refers to "example" rather than "ideal". In addition, the terms "first", "second", etc. do not represent any order, quantity or importance in this article, but are used to distinguish an element or structure from another element or structure. In addition, the terms "one" and "a kind" herein do not represent a quantitative limitation, but represent the presence of one or more cited items.
[0051] The term "distal end" or any variation thereof refers to the portion of the device that is the drug delivery end. Conversely, the term "proximal end" or any variation thereof refers to the portion of the device that is the actuation end. Furthermore, when used herein, the terms "about," "substantially," and "approximately" generally mean + / - 10% of the indicated value.
[0052] It is worth noting that, for simplicity and clarity of illustration, certain aspects of the drawings depict the general structure and / or construction of various embodiments. Descriptions and details of well-known features and techniques may be omitted to avoid unnecessarily obscuring other features. The elements in the drawings are not necessarily drawn to scale; the dimensions of some features may be exaggerated relative to other elements to improve understanding of the example embodiments. For example, it should be understood by those of ordinary skill in the art that side views are not drawn to scale and should not be considered to represent proportional relationships between different components. Side views are provided to help illustrate the various components of the depicted assembly and to show their relative positioning to each other. DETAILED DESCRIPTION
[0053] Reference will now be made in detail to examples of the present disclosure, which are depicted in the accompanying drawings. Wherever possible, the same reference numerals will be used throughout the drawings to refer to the same or like parts.
[0054] With the use of drug delivery devices, various safety concerns may occur. Safety issues and concerns may occur before, during and / or after use (i.e., injecting products (e.g., liquid medicaments) from drug delivery devices). For example, if the components of the device are not fixed and / or locked to appropriate pre-injection (pre-injection) positions, premature discharge of the product may occur. If the device is accidentally removed from the injection site, and / or after injection when the device is removed from the injection site and discarded, the exposure of the needle may cause unexpected needle sticks. The exposure of the needle may also have an adverse effect on users suffering from needle phobia and / or needle-related anxiety. In addition, there may be concerns that the user inserts and / or injects the needle into the injection site with an incorrect depth.
[0055] In order to address these concerns, traditional safety devices have been developed. Traditional safety devices may include active safety mechanisms. Active safety mechanisms refer to such mechanisms in which users need to actively perform specific actions to trigger the safety mechanism. For non-professional users (i.e. users who have not received medical training), it may be difficult to properly activate the active safety mechanism while properly injecting the drug into themselves or another person. In addition, if the user fails to start the safety mechanism, the active safety mechanism may not have any effect. Passive safety mechanisms have been developed to address these problems. The device including the passive safety mechanism does not require the user to perform any additional and / or separate actions to trigger the safety mechanism before, during and / or after using the device. However, with the use of passive drug delivery devices, other concerns may occur. For example, if the user accidentally removes the device from the injection site, the passive safety mechanism can be automatically activated before completing the dose. In this case, the user may not be able to complete the dose and has to obtain another device.
[0056] Embodiments of the present disclosure relate to drug delivery devices, and in particular, to devices for passively activating a safety mechanism during and / or after injection of a drug from a product container (ie, a syringe).
[0057] Figure 1A An external view of the device 10 is shown. The device 10 may be designed to hold any commercially known product container 12 (eg, a syringe or other suitable drug delivery device). The device 10 may include a housing 14, a plunger rod 16, and a thumb pad 20. Figure 1B An internal view of the device 10 is shown, wherein the housing 14 may be configured to accommodate the container 12. Figure 1B In the illustrated embodiment, the container 12 may be a syringe, such as a prefilled syringe. The housing 14 may include an inwardly projecting shoulder 28. Figure 1BAs shown, the shoulder 28 can be located in the proximal portion of the housing 14 and can abut the proximal end of the container 12 when received in the housing 14. The plunger rod 16 can include a stopper 18 for expelling product from the container 12 and a flange 26 for coupling to the thumb pad 20. Figure 1B , the stopper 18 may be positioned at the distal end of the plunger rod 16 , and the flange 26 may be positioned at the proximal end of the plunger rod 16 .
[0058] As will be described in detail below, the plunger rod 16 can abut and / or releasably couple to a portion of the syringe in the housing 14, such as the piston of the syringe. In some embodiments, the plunger rod 16, the thumb pad 20, and the syringe can be locked together during injection, thereby transmitting the user's force on the plunger rod 16 to the piston of the syringe. After the injection is completed, the plunger rod 16 can be decoupled from the syringe. After the plunger rod 16 is decoupled from the syringe, the thumb pad 20 can be coupled to the housing 14, thereby preventing the thumb pad 20, the plunger rod 16, and / or the syringe from moving in the proximal direction. When the thumb pad 20 moves in the distal direction to the housing 14, the spring 13 can move the syringe in the proximal direction into the housing 14.
[0059] Various components may be utilized to move the plunger rod 16 and / or syringe and then lock the thumb pad 20, plunger rod 16, and / or syringe into the housing 14. In some embodiments, the thumb pad 20 may include a deflectable tab 22 and a distal extension 24. Figure 2B As shown, the deflectable tab 22 may include a recess 23. The recess 23 may be releasably coupled to a flange 26 of the plunger rod 16. In some embodiments, the deflectable tab 22 and the recess 23 may be formed continuously or around a majority of the interior of the thumb pad 20. In other words, the deflectable tab 22 and the recess 23 may be formed in the thumb pad 20 to surround the flange 26. In other embodiments, the thumb pad 20 may include more than one deflectable tab 22 and recess 23. For example, the thumb pad 20 may include two deflectable tabs, three deflectable tabs, or four deflectable tabs, each of which has a recess 23. In configurations with more than one deflectable tab 22 and recess 23, the tabs may be equally spaced from one another. For example, if the thumb pad 20 includes four deflectable tabs, each tab may be approximately 90 degrees from one another. Additionally, each deflectable tab may include a recess 23 for releasably coupling to a portion of a flange 26 .
[0060] In some embodiments, the thumb pad 20 can include more than one distal extension 24. For example, the thumb pad 20 can include two, three, four, or more distal extensions 24. In configurations with more than one distal extension 24, the distal extensions can be equally spaced from one another. For example, if the thumb pad 20 includes four distal extensions 24, each distal extension can be approximately 90 degrees from one another. In some embodiments, a single distal extension can extend continuously or at least partially around the thumb pad 20.
[0061] Prior to injection, the plunger rod 16 may be fully extended from the proximal end of the housing 14 ( Figure 1B ). In this configuration, the container 12 (e.g., a filled syringe) and the plunger rod 16 may not be removed from the device 10. Various components may prevent the plunger rod 16 from being removed from the device 10. For example, the arm 36a of the thumb pad 20 may lock into the housing 14 to prevent removal of the plunger rod 16. Figure 2A-2B To begin injecting product from container 12, the user may depress thumb pad 20 to move thumb pad 20 and plunger rod 16 in a distal direction toward housing 14. After the product is completely expelled from container 12 at the end of the injected dose, thumb pad 20 may abut the proximal end ( Figure 2B The proximal end of the housing 14 may include a collar 30 aligned with the deflectable tab 22. Figure 2B As shown, the collar 30 may have a ramp configured to abut and deflect the deflectable tab 22 in an outward direction away from the flange 26 when the injection dose is completed. The deflectable tab 22 may also include a ramp surface configured to abut the ramp surface of the collar 30 to facilitate deflection of the deflectable tab 22. The thumb pad 20, tab 22, and recess 23 may be decoupled from the flange 26 and release the plunger rod 16. Figure 2A Also depicted is the arm 36a of the thumb pad 20 which will be described in greater detail below with reference to the latching features of the device 10 .
[0062] Also like Figure 2B As shown, once the thumb pad 20 abuts the housing 14 at the end of an injected dose, the distal extension 24 of the thumb pad may contact the shoulder 28 of the housing 14 and deflect it in an outward direction away from the plunger rod 16 . Figure 2C The distal extension 24 and shoulder 28 are depicted prior to being moved into contact with each other, and Figure 2DThe distal extension 24 of the thumb pad 20 is depicted when the distal extension 24 of the thumb pad 20 begins to contact the shoulder 28. Once the shoulder 28 is deflected in an outward direction away from the plunger rod 16 and the proximal end of the container 12, the container 12 can be released, thereby allowing the container 12 to move in the proximal direction. In some examples, the spring 13, such as a spring guard (coil spring), can abut a portion of the container 12 in the housing 14 so as to push the container 12 in the proximal direction once the container 12 is released from the shoulder 28. For example, the at least partially compressed spring 13 can contact the distal surface of the flange of the container 12, and when the shoulder 28 is deflected outward and no longer abuts the container 12, the spring can push the distal surface of the flange of the container 12 in the proximal direction, and thus push the entire container 12. With this spring, a locking function can be provided to the device 10 to prevent reuse of the device. One spring can surround the container 12 in the housing 14, or one or more springs can be located adjacent to the container 12 and can abut the distal surface of a portion of the container 12.
[0063] Figure 2E The device 10 is depicted when the thumb pad 20 initially abuts the proximal end of the housing 14 before the device 10 is occluded, and Figure 2F The device 10 is depicted once locked, with the plunger rod 16 and flange 26 positioned in the thumb pad 20 such that the flange 26 abuts the distal inner wall 32 of the thumb pad 20. Once the plunger rod 16 and flange 26 are released from the recess 23 of the deflectable tab 22, and the distal end of the container 12 is released from the shoulder 28, the plunger rod 16, flange 26 and container 12 can be moved in a proximal direction toward the distal inner wall 32 of the thumb pad 20 ( Figure 2F ).
[0064] In some embodiments, the thumb pad 20 may include one or more arms, such as arms 36a and 36b that extend distally into the housing 14 when the thumb pad 20 is depressed. The distal ends of the arms 36a, 36b may protrude radially outward away from the container 12, and the arms 36a, 36b may be biased radially outward. The housing 14 may include a pair of cutouts 34a, 34b. When the thumb pad 20 abuts the distal end of the housing 14, the release flange 26, the plunger rod 16, and the container 12, the protrusions on the distal ends of the arms 36a, 36b may align with the cutouts 34a, 34b and may be deflected outward to engage the cutouts 34a, 34b ( Figure 2E The engagement of the distal ends of the arms 36a, 36b with the cutouts 34a, 34b can hold the thumb pad 20 in place as the flange 26 moves proximally to abut the distal inner wall 32 of the thumb pad 20 ( Figure 2F ). It also serves to lock the thumb pad 20 to the housing 14, preventing the device 10 from being reused.
[0065] In some embodiments, multiple arms can extend distally from the thumb pad 20. For example, the thumb pad 20 can include two, three, four or more arms 36a, 36b. In configurations with more than one arm, the arms can be equally spaced from each other. For example, if the thumb pad 20 includes four arms, each arm can be approximately 90 degrees from each other. If the thumb pad 20 includes two arms, each arm can be approximately 180 degrees from each other. In addition, when the thumb pad 20 is in the most distal position, the housing 14 can include a corresponding number of cutouts aligned with the protrusions on the distal ends of the arms. In some embodiments, a single arm can extend from the thumb pad 20, and the housing 14 can include a single cutout aligned with the arm. In some embodiments, the thumb pad 20 can include two arms, and the housing 14 can include two cutouts, one for each arm, and so on. Although the cutouts 34a, 34b are depicted as extending through the wall of the housing 14, it is contemplated that the cutouts 34a, 34b can be indentations or grooves that may not extend completely through the housing 14. In embodiments where the cutouts are grooves, one or more grooves may be positioned in line with the arms on thumb pad 20 , or a single groove may extend around the inner wall of housing 14 .
[0066] Figures 1A to 2F The embodiment depicts a device having a passive safety mechanism that can be activated when the user approaches end-of-dose (ie, when a large amount of product is completely expelled from the container 12). Figures 1A-2F The passive safety mechanism can allow the container 12 and the injection needle 2 ( Figure 1B ) is moved proximally into the housing 14 at the end of the dose so that the injection needle 2 can be fully retracted into the housing 14 to prevent accidental needle sticks after the injection. The container 12 and injection needle 2 may not be moved proximally into the housing 14 until the injection is complete and the thumb pad 20 is pressed against the proximal end of the housing 14 to release the flange 26 and the container 12. Figure 1A to Figure 1B As shown, the user can see only a portion of the needle 2. This can prevent needle phobia and needle-related anxiety compared to traditional drug delivery devices with exposed needles. In addition, exposing only a portion of the needle 2 can allow the device 10 to be used without any pre-injection steps (e.g., pinching the skin to change the injection depth to compensate for the longer needle length compared to the exposed needle 2 of the device 10). The dimensions of the device 10 can be designed so that the starting position of the container 12 within the housing 14 is calibrated so that only a portion of the needle is exposed, and the length of the exposed portion of the needle 2 represents the desired insertion depth of the needle 2.
[0067] In some embodiments, the device 10 may include a feedback mechanism. The device 10 may include a visual feedback mechanism, for example, the thumb pad 20 and the housing 14 lock together and the needle 2 retracts into the housing 14 so that the user cannot see the needle 2 once the device 10 is pulled away from the injection site. In some examples, the device 10 may include an optional opening 40 ( Figure 1B ) for observing the container 12 and the movement of the plunger rod 16 and the stopper 18 in the container 12. In some aspects, the device 10 can include an audible feedback mechanism, such as an audible "click" sound once the thumb pad 20 and the housing 14 are connected and / or once the flange 26 abuts the distal inner wall 32 of the thumb pad 20. In some aspects, the device 10 can include tactile feedback, such as a snap or vibration when the thumb pad 20 and the housing 14 are connected and / or once the flange 26 abuts the distal inner wall 32 of the thumb pad 20.
[0068] The device 10 can have any suitable size and shape to hold or partially hold the product container 12, and / or to support and hold the plunger rod 16 and stopper 18 in the product container 12. The thumb pad 20 can have any suitable size and shape to abut and lock into the device 10. The components of the thumb pad 20 (including the deflectable tab 22 and the recess 23) can have any suitable size and shape to receive the flange 26. The cutouts 34a, 34b can have any suitable size and shape to receive the arms 36a, 36b.
[0069] In other embodiments, the device 10 may include a rear cap 170 ( Fig.17A and 17B ).like Fig. 17B As shown, the rear cap 170 can be shaped and configured to fit into the proximal end of the housing 14. The rear cap 170 can have a generally circular shape. The proximal end of the rear cap 170 can abut the proximal end of the housing 14 so that the rear cap 170 can be fixed in the housing 14. Fig. 17B , the rear cap 170 may include a rear cap recess 172 for receiving a portion of the syringe 12. For example, the proximal portion of the syringe 12 may fit into the rear cap recess 172 of the rear cap 170. The thumb pad 20 of the device 10 may include a deflectable tab 22. In some embodiments, the thumb pad 20 may include a plurality of deflectable tabs 22. The deflectable tab 22 may include a recess 23 configured to receive a flange 26 of the plunger rod 16. The thumb pad 20 may also include a proximal extension 24. In some embodiments, the thumb pad 20 may include a plurality of proximal extensions 24. Fig. 17C Depicted Fig. 17B A rotated rear view of the device 10 in FIG. Fig. 17C , the plunger rod 16 may include a plurality of ridges 16 a , wherein portions of the rear cap 170 may abut against portions of the ridges 16 a .
[0070] During use, the user may press the thumb pad 20 in a distal direction toward the housing 14. Figure 2A and 2B And reference Fig.17D and 17E In the described mechanism, when the thumb pad 20 is pushed toward the housing 14, a portion of the proximal end of the housing 14 abuts against the deflectable tab 22. The deflectable tab 22 can be deflected in a direction away from the flange 26, thereby allowing the plunger rod 16 and the thumb pad 20 to be decoupled. Fig.17E Depicted Fig.17D A rotated rear view of the device 10 in FIG. Fig.17F , at the end of the dose, the distal end of the extension 24 can snap into the housing 14. For example, the housing 14 may include a cutout 174 for receiving the distal end of the extension 24. Once the distal end of the extension 24 snaps into the cutout 174, the distal end of the extension 24 can press a portion of the rear cap 170 inwardly toward the plunger rod 16, thereby allowing the rear cap 170 to move in a proximal direction into the thumb pad 20. The device 10 may include an actuator (not shown), such as a spring, below the rear cap 170. The actuator may be configured to push the rear cap 170 into the thumb pad 20 once a portion of the rear cap 170 is pressed inwardly toward the plunger rod 16. Figure 17G Depicted Fig.17F FIG. 1 is a view of a rotation of the device 10 .
[0071] Fig.18A and 18B An alternative embodiment of the device 10 is depicted. Fig.18A depicts a front exterior view of the device 10, and Fig.18B A side exterior view of the device 10 is depicted. The housing 14 of the device 10 may include a finger flange 15. The finger flange 15 may be located at a proximal end of the housing 14 and extend in a direction away from the plunger rod 16. The finger flange 15 may be shaped or configured to be properly held by a user and to be properly operable with a syringe. For example, the finger flange 15 may be designed to meet safety requirements and necessary needle distance requirements. Reference Fig.18B , the housing 14 may include a rear cap 190. In this embodiment, the rear cap 190 may be located at the proximal end of the housing 14. The rear cap 190 may include a hook portion 192 extending in the proximal direction. Fig.18B As shown, the rear cap 190 may include at least two hooks 192. The hooks 192 may abut against the recessed portion 180 (at Fig.19A and 19B). The hook portion 192 may be hooked onto the proximal surface of the recessed portion 180, ie, located at the top of the proximal surface of the recessed portion 180.
[0072] Fig.19A and 19B Depicted Fig.18A and 18B sectional view of the device 10 in FIG. Fig.19A is a front cross-sectional view of the device 10, and Fig.19B is a side cross-sectional view of the device 10. The cap 20 may include a proximal extension 24, and the housing 14 may include a finger flange 15. As discussed above, the finger flange 15 may include a rear cap 190, wherein the rear cap 190 may include a hook portion 182 that may be hooked onto the recessed portion 180 of the plunger rod 26. Fig.19A The housing 14 may also include a shoulder 28. Further details of the housing 14 and rear cap 190 will be discussed below.
[0073] Figures 20A-20C A view of the device 10 is depicted in a pre-injection state. Fig. 20A A quarter cross-sectional view of the device 10 is depicted, Fig. 20B Depicted from Fig. 20A A detailed view of the proximal end of the housing 14 and the rear cap 190, and Fig. 20C Depicted from Fig. 20A Detailed view of thumb pad 20. Reference Fig. 20B , the rear cap 190 and the housing 14 may include an attachment device for attaching the rear cap 190 to the housing 14. For example, the rear cap 190 may include a snap 201, and the housing 14 may include an insert (not shown) to allow the rear cap 190 and the housing 14 to snap together. The rear cap 190 may include a tab 203, and the housing 14 may include a housing hook 205. When the rear cap 190 and the housing 14 are attached ( Fig. 20B ), tab 203 can be located in a portion of housing 14, and housing hook 205 can be hooked onto a portion of tab 203, i.e., located on top of a portion of tab 203. This configuration can be used as an anti-pullback feature to prevent a user from inadvertently pulling plunger rod 14 out of the back of device 10. This configuration can also be used as a pre-discharge prevention to prevent loss of drug product before the needle is inserted into the skin. Fig. 20C In one embodiment, the thumb pad 20 may include a deflectable tab 22 and a proximal extension 24 . Fig. 20C Depicted from Fig. 20A A quarter cross-sectional view of the thumb pad 20 of FIG. The thumb pad 20 may include a plurality of deflectable tabs 22 and a proximal extension 24. Fig. 20C, a portion of the flange 26 of the plunger rod 14 abuts against the distal surface of the recess (indent) 27 of the deflectable tab 22. In addition, a portion of the flange 26 can also be located on top of the proximal surface of the boss portion 29 of the distal extension 24. Figures 21A-21C Describes when Figures 18A-20C The device 10 in the injection state is transformed to the device 10 in the post-injection, i.e., end-of-dose state. At the start of an injection, the needle of the syringe 12 (not shown) can be extended distally from the housing 14. For example, at the start of an injection, about 6 mm of the needle can be exposed. When the user presses the thumb pad 20 toward the housing 14 in the distal direction, the plunger rod 16 can also extend distally into the syringe 12, thereby allowing the recessed portion 180 to disengage from the hook portion 192. Fig.21B Once the thumb pad 20 abuts the rear cap 190, the deflectable tab 22 can be deflected outwardly in a direction away from the flange 26, thereby allowing the deflectable tab 22 to disengage from the flange 26. Once the thumb pad 20 abuts the rear cap 190, the distal extension 24 can abut the shoulder 28, thereby pushing the shoulder 28 outwardly in a direction away from the syringe 12. The syringe 12 and the plunger rod 16 can then be moved in a proximal direction so that the flange 26 of the plunger rod 16 can abut the distal surface ( Fig. 21C ). Then, the needle 70 of the syringe 12 can be housed within the housing 14 ( Fig.21A The passive end-of-dose lockout mechanism may be activated by an actuator (e.g., spring 13) which may be located around the proximal end of the syringe 12 ( Figure 1B ).
[0074] Figures 18A-21C Embodiments of the device 10 depicted in the drawings may include one or more additional features, such as features for locking the thumb pad 20 in place with the plunger rod 16 in a post-injection state; alignment features between the thumb pad 20 and the plunger rod 16 to reduce misalignment at the end of an injection; ergonomic design to enable two-handed operation, i.e., one hand can hold the syringe at 90 degrees for needle insertion while the second hand pushes the plunger rod 16; optimal construction and size design of the deflectable tab 22, distal extension 24, plunger rod 16 and / or rear cap 190; an indicator of injection completion, such as a visual color change or an audible indicator; an activation point for mitigating potential failure modes, such as a pre-activation point or state; optimal construction and size design of the thumb pad 20 to fit the user's hand; an extension of the plunger rod 16 to seat within the piston of the device to improve alignment; and an optimized design to reduce the required spring force to minimize plastic creep.
[0075] Figures 3A-5D Another embodiment of the present disclosure is depicted wherein the needle is covered in a pre-injection state. Figure 3A-3BThe device 50 can be designed to hold any conventional product container 52, such as a syringe. The device 50 can include a housing 54, a plunger rod 56, a stopper 60, a blocking member 62, and a needle cover 64. Figure 3B As shown, for example, the plunger rod 56 may include a first recess 58 at a distal region and a second recess 59 at a proximal region. The blocking member 62 may be located at the proximal end of the housing 54. The plunger rod 56 may be slidably coupled to the blocking member 62 so that the plunger rod 56 can slide through the blocking member 62 in a distal direction. The needle cover 64 may include a proximal end 66 that abuts against a deflectable arm 63 of the blocking member 62. Figure 3A-3B As shown, the blocking component 62 may include more than one deflectable arm 63. For example, the blocking component 62 may include two, three, four or more deflectable arms 63. In a configuration with more than one deflectable arm, the deflectable arms may be equally spaced from one another. For example, if the blocking component 62 includes four deflectable arms 63, each deflectable arm may be approximately 90 degrees from one another. For example, the blocking component 62 may have a pair of deflectable arms 63 (e.g., spaced approximately 180 degrees from one another). Therefore, the discussion herein may apply to devices having different numbers of components. In some examples, the needle cover 64 may include a slot 55 ( Figures 3A-4D ), the slot 55 is configured to receive a portion of the housing 54. The slot 55 will be further described below.
[0076] Figure 3A The device 50 is depicted prior to use, wherein the needle cover 64 may be fully extended distally of the housing 54 and covering the needle 70 in an initial starting position. Figure 3B The device 50 is depicted during use, once the needle cover 64 is depressed and moved proximally into the housing 54, such as by pressing the device 50 against an injection site. The detailed construction and interaction of the needle cover 64 and the barrier member 62 will be further described when use of the device 50 is discussed.
[0077] In the initial position before use, such as Figures 4A-4B As shown, the distal end of the deflectable arm 63 can fit into a portion of the first recess 58 of the plunger rod 56. For example, the distal portion of the deflectable arm 63 can abut a portion of the first recess 58 at contact point A. The distal end 66 of the needle cover 64 can also abut a portion of the deflectable arm 63 at contact point B. In this initial position, prior to use, the plunger rod 56 can be prevented from significant movement in the proximal or distal direction. For example, as Figures 4A-4B As shown, if the plunger rod 56 is pushed into the housing 54 in the distal direction, the proximal end 66 of the needle cover 64 prevents the deflectable arm 63 from deflecting outward, thereby locking the deflectable arm 63 in the first recess 58 and preventing further movement of the plunger rod 56. Figure 4C-4D As shown, if the plunger rod 56 is pulled in a proximal direction away from the housing 54 , the proximal end 66 of the needle cover 64 prevents the deflectable arms 63 from deflecting outwardly, thereby locking the deflectable arms 63 within the first recess 58 and preventing further movement of the plunger rod 56 .
[0078] To initiate an injection, the device 50 may be pressed against the injection site to depress the needle cover 64. Once the needle cover 64 moves distally, the proximal end 66 of the needle cover 64 moves proximally away from engagement with the deflectable arm 63. This may allow the plunger rod 56 to be pressed in the distal direction toward the housing 54 for injection. In other words, when the needle cover 64 moves proximally into the housing 54 and the proximal end 66 moves away from the contact point B, the plunger rod 56 may deflect the arm 63 of the blocking member 62, thereby allowing the first recess 58 to move past the deflectable arm 63 ( Figure 5A ) so that the injection can be performed. Figure 5A As shown, the proximal end 66 of the needle cover 64 is moved proximally in the housing and may abut a portion of the blocking member 62 .
[0079] Once the injection is complete, the device 50 can be removed from the injection site and the needle cover 64 can be pulled downward in the distal direction ( Figure 5B-5C ). In some examples, the device 50 may include a spring guard (coil spring) 53 ( Figure 3A and Figures 5A-5D ) to pull the needle cover 64 and bias the needle cover 64 in the proximal direction. Figure 5B-5C As shown, the plunger rod 56 is fully pressed into the housing 54. Figure 4A and Figure 4C As shown, the diameter of the portion of the plunger rod 56 at the second recess 59 can be smaller than the portion of the plunger rod 56 at the first recess 58, thereby creating a second recess 59 that is larger than the first recess 58. Therefore, once the plunger rod 56 is fully depressed into the housing 54 at the end of an injection, there is an increased area ( ) between the plunger rod 56 and the deflectable arm 63 at the second recess 59. Figure 5B ). This space can allow the proximal end 66 of the needle cover 64 to flex the deflectable arm 63 inwardly toward the plunger rod 56 so that the proximal end 66 can move past the deflectable arm 63 in the distal direction ( Figure 5C ). In some examples, there may be a spring guard 53 around the needle cover 64, where the needle cover 64 may be moved past the deflectable arm 63 using a spring force. Figure 5DOnce the proximal end 66 has passed the deflectable arm 63, the deflectable arm 63 can return to the undeflected position and the deflectable arm 63 can prevent the proximal end 66 from moving in the proximal direction again. The deflectable arm 63 can now act as a lockout mechanism to prevent reuse of the device 50 or accidental needle sticks because the needle cover 64 can no longer move proximally to expose the needle 70. In this final post-injection position of the device 50, the needle cover 64 can be in the lockout position and the proximal end 66 and the deflectable arm 63 can abut at the contact point C ( Figure 5D ). The needle cover 64 and the proximal end 66 are prevented from further movement, wherein the proximal end 66 is retained between the boss portion 72 of the housing 54 and the deflectable arm 63. In addition, the device 50 cannot be reused.
[0080] In some embodiments, the slot 55 of the needle cover 64 can be configured to slidably receive the boss 72. For example, when the needle cover 64 moves, the boss 72 can move within the slot 55. The boss 72 can move in the distal and / or proximal directions within the slot 55. As described above, in the post-injection position of the device 50, the proximal end 66 can be retained between the boss 72 of the housing 54 and the deflectable arm 63, wherein the boss 72 can be within the slot 55. Figure 3A As shown, the needle cover 64 may include a corresponding number of slots aligned with the boss 72 of the housing 54. In some embodiments, the housing 54 may include a single boss, and the needle cover 64 may include a single slot aligned with the boss. In some embodiments, the housing 54 may include two bosses, and the needle cover 64 may include two slots, one aligned with each boss, and so on. The slot 55 may extend through the needle cover 64. In other embodiments, the slot 55 may be a depression or groove that does not extend completely through the needle cover 64.
[0081] Figures 3A-5D The embodiment depicts a device having a passive safety mechanism that can be activated when the user is nearing the end of the dose (ie, when a large amount of product is completely expelled from the container 52). Figures 3A-5D The passive safety mechanism can prevent accidental post-injection needle sticks because the needle cover 64 is not depressed until the device 50 is pressed against the injection site, and once the device 50 is removed from the injection site, the needle cover 64 rebounds to extend from the distal end of the housing 54 to cover the needle 70.
[0082] in addition, Figures 3A-5D Passive safety mechanisms can prevent premature occlusion. For example, some conventional drug delivery devices can automatically occlude once the device is removed from the injection site, even if the product has not been fully expelled. Figure 5C-5DOnly when the plunger rod 56 is fully depressed into the housing 54 can the proximal end 66 of the needle cover 64 flex the deflectable arm 63 into the second recess 59 so that the proximal end 66 can move in the distal direction past the deflectable arm 63 to a position adjacent to the boss 72 to abut the deflectable arm 63 at the contact point C. The plunger rod 56 is fully depressed only at the end of the dose, so that lockout does not occur before the entire dose of product in the container 52 is expelled. If the device 50 is removed from the injection during the injection (i.e., before the plunger rod 56 is fully depressed into the housing 54), the needle cover 64 may not be locked, and the device 50 may be placed back on the injection site to continue the injection.
[0083] Additionally, because needle 70 is within needle cover 64 before and after injection, the user may not be able to see needle 70 at any point before, during, and / or after the injection. Thus, needle cover 64 may reduce needle phobia and needle-related anxiety compared to conventional drug delivery devices with exposed needles. Additionally, exposing only a portion of needle 70 may allow device 50 to be used without any pre-injection steps (e.g., pinching the skin to change the injection depth to compensate for the longer needle length compared to the exposed needle 70 of device 50). Figure 3B The device 50 can be configured, for example, the container 52 can be positioned within the housing 54 and / or the needle cover 64 can be sized so that the retracted position of the needle cover 64 exposes only a portion of the needle 70, and the length of the exposed portion of the needle 70 represents the desired insertion depth of the needle 70.
[0084] In some embodiments, the device 50 may include a feedback mechanism. The device 50 may include a visual feedback mechanism, for example, when the plunger rod 56 is fully depressed into the housing 54 ( Figure 5B ), the needle cover 64 is fully extended to the proximal side of the housing 54, and the needle 70 is covered. In some examples, the device 50 may include an opening for observing the container 52 and the movement of the plunger rod 56 and the stopper 60 in the container 52. The device 50 may also include an auditory feedback mechanism, for example, an auditory "click" sound once the proximal end of the plunger rod 56 and the housing 54 are connected. In some aspects, the device 50 may include tactile feedback, for example, a snap or vibration when the needle cover 64 moves proximally and abuts the boss 72 at the end of the injection.
[0085] Figure 6A-6B Another embodiment of the present disclosure is described, Figures 3A-5D Similar to those described above, but in which the needle extends beyond the needle cover in the pre-injection state. Where appropriate, features will be designated with similar reference numerals to those discussed above. Figures 3A-5D Any features and components corresponding to those in the reference may be understood to be similarly constructed. Figure 6A-6B, the device 80 can be designed to hold any conventional product container 92, such as a syringe. The device 80 may include a housing 74, a plunger rod 76, a stopper 90, a blocking member 82, and a needle cover 84. Figure 6B As shown, for example, the plunger rod 76 may include a first recess 78 at a distal region and a second recess 79 at a proximal region. The blocking member 82 may be located at the proximal end of the housing 74. The plunger rod 76 may be slidably coupled to the blocking member 82 such that the plunger rod 76 may slide through the blocking member 82. Figure 6A-6B As shown, the blocking component 82 can include more than one deflectable arm 83. For example, the blocking component 82 can include two, three, four or more deflectable arms 83. In the configuration with more than one deflectable arm, the deflectable arms can be equally spaced apart from each other. For example, if the blocking component 82 includes four deflectable arms 63, each deflectable arm can be about 90 degrees to each other. For example, the blocking component 82 can have a pair of deflectable arms 83 (e.g., spaced apart from each other by about 180 degrees). Therefore, the discussion herein can be applicable to devices with different numbers of components.
[0086] Fig. 6A The device 80 is depicted prior to use, with the needle 96 extending distally from the housing 74 and the needle cover 84. An optional removable needle shield 94 may be inserted into or over the needle cover 84 and / or the housing 74 to cover the needle 96. Figure 6B The device 80 is depicted prior to use once the needle shield 94 has been removed. Figure 3A-3B Unlike the embodiment of the present invention, since the needle 96 extends beyond the needle cover 84 in the initial state of the device, it may not be necessary to press down the needle cover 84 before use. Before injection, once the needle shield 94 is removed, the needle 96 is visible to the user.
[0087] In the initial position before use, such as Figure 7A-7BAs shown, the distal end of the deflectable arm 83 can fit into at least a portion of the first recess 78 of the plunger rod 76. For example, the distal portion of the deflectable arm 83 can abut a portion of the first recess 78 at a contact point E. The proximal end 86 of the needle cover 84 can also abut a portion of the deflectable arm 83 at a contact point D. In this initial position, prior to use, significant movement of the plunger rod 76 in the proximal or distal direction can be prevented. For example, if the plunger rod 76 is pushed into the housing 74 in the distal direction using a normal injection force, the contact between the deflectable arm 83 and the plunger rod 76 at the contact point E and the contact between the proximal end 86 of the needle cover 84 can prevent the plunger rod 76 from moving proximally. The arrangement of the deflectable arm 83, the plunger rod 76 having the first recess 78, and the proximal end 86 of the needle cover 84 can prevent the plunger rod 76 from moving in the distal direction unless an increased amount of force, i.e., a force higher than a typical injection force, is applied. If the plunger rod 76 is pulled in the proximal direction away from the housing 74 , the deflectable arm 83 may contact an edge of the first recess 78 , thereby preventing the plunger rod 76 from moving in the distal direction.
[0088] To initiate an injection, the device 80 may be pressed against the injection site, thereby allowing the needle 96 to pierce the injection site. The plunger rod 76 may then be pushed in a distal direction toward the housing 74 using a force that is higher than a normal injection force. When the plunger rod 76 is pressed into the housing 74, the deflectable arm 83 may deflect radially outward in a direction away from the plunger rod 76 and the contact point E when subjected to a higher than normal break loose force, thereby allowing the first recess 78 to move past the deflectable arm 83 ( Figure 7C ). A higher than normal break-away force may be, for example, a force higher than about 2 Newtons (N), such as about 3N to about 20N.
[0089] Once the injection is complete, the device 80 can be removed from the injection site and Fig.7D As shown, the plunger rod 76 is fully depressed into the housing 74 so that the plunger rod 76 abuts the housing 74. Once the device 80 is removed from the injection site, the needle cover 84 includes the spring guard 73 ( Fig. 6A ) to move the needle cover 84 downward in the distal direction. Figure 6A-6B As shown, the diameter of the portion of the plunger rod 76 at the second recess 79 can be smaller than the portion of the plunger rod 76 at the first recess 78, thereby creating a second recess 79 that is larger than the first recess 78. Therefore, once the plunger rod 76 is fully depressed into the housing 74 at the end of an injection, there is an increased area ( ) between the plunger rod 76 and the deflectable arm 83 at the second recess 79. Fig.7D ). This space can allow the proximal end 86 of the needle cover 84 to flex the deflectable arm 83 inwardly toward the plunger rod 76 so that the proximal end 86 can move past the deflectable arm 83 in the distal direction ( Fig. 7E ). In some examples, there may be a spring guard 53 (not shown) around the needle cover 84 or at one end of the needle cover 84, wherein the needle cover 84 may move past the deflectable arm 83 using a spring force. Fig. 7E Once the distal end 66 has passed the deflectable arm 83, the deflectable arm 83 can bend back to its initial position, and the deflectable arm 83 can prevent the needle cover 84 from moving in the proximal direction again. The deflectable arm 83 can now act as a lockout mechanism to prevent reuse of the device 80 or accidental needle sticks, because the needle cover 84 can be extended further distally than the initial position so that the needle cover 84 covers the needle 96. In the final post-injection position of the device 80, the needle cover 84 can be extended distally in the lockout position, and the needle cover 84 can abut the boss 98 at the contact point F, thereby preventing the needle cover 84 from moving further in the distal direction. The proximal end 86 of the needle cover 84 can also abut the distal end of the deflectable arm 83, so that the needle cover 84 and the proximal end 86 can be prevented from moving further proximally.
[0090] In some examples, needle cover 84 may include slot 75 ( Fig. 6A ), the slot 75 is configured to receive a portion of the housing 74. In some embodiments, the slot 75 of the needle cover 84 can be configured to slidably receive the boss 98. For example, when the needle cover 84 moves, the boss 98 can move within the slot 75. The boss 98 can move in the distal and / or proximal directions within the slot 75. As described above, in the post-injection position of the device 80, the proximal end 86 can be maintained between the boss 98 of the housing 74 and the deflectable arm 83, wherein the boss 98 can be within the slot 75. Fig. 6A As shown, the needle cover 84 may include a corresponding number of slots aligned with the bosses 98 of the housing 74. In some embodiments, the housing 74 may include a single boss, and the needle cover 84 may include a single slot aligned with the boss. In some embodiments, the housing 74 may include two bosses, and the needle cover 84 may include two slots, one aligned with each boss, and so on. The slot 75 may extend through the needle cover 84. In other embodiments, the slot 75 may be a depression or groove that may not extend completely through the needle cover 84.
[0091] Figures 6A-7F The embodiment depicts a device having a passive safety mechanism that can be activated when the user is nearing the end of the dose (ie, when a large amount of product is completely expelled from the container 92). Figures 6A-7F Passive safety mechanisms can also prevent premature occlusion. For example, some conventional drug delivery devices can automatically occlude once the device is removed from the injection site, even if the product has not been fully expelled. Figure 7D-7FOnly when the plunger rod 76 is fully depressed into the housing 74 can the proximal end 86 of the needle cover 84 flex the deflectable arm 83 into the second recess 79 so that the needle cover 84 can move past the deflectable arm 83 in the distal direction and then abut the boss 98 at the contact point F. Once the plunger rod 76 is fully depressed, the entire dose of product in the container 92 can be expelled. If the device 80 can be removed from the injection during the injection site (i.e., before the plunger rod 76 is fully depressed into the housing 74), the needle cover 84 can be unlocked and the device 80 can be put back on the injection site to continue the injection.
[0092] In addition, because a portion of the needle 96 is within the needle cover 84, the user may only see a portion of the needle 96 at any point before and / or during the injection. Because the needle cover 84 can be extended from the proximal end of the housing 74 to cover the needle 96 after the injection, the user may not see any portion of the needle 96 at the end of the dose. Therefore, the needle cover 84 can reduce needle phobia and needle-related anxiety compared to traditional drug delivery devices with exposed needles. In addition, exposing only a portion of the needle 96 can allow the device 80 ( ) to be used without any pre-injection steps (e.g., squeezing the skin to change the injection depth to compensate for the longer needle length compared to the exposed needle 96 of the device 80). Figure 6B ). The device 80 can be configured such that, for example, the container 92 can be positioned within the housing 74 and / or the needle cover 84 can be sized such that the needle cover 84 exposes only a portion of the needle 96, and the length of the exposed portion of the needle 96 represents the desired insertion depth of the needle 96.
[0093] refer to Figure 7C , the safety mechanism can also prevent pre-discharge of product. As described above, the force applied to the plunger rod 76 by the deflectable arm 83 and the proximal end 86 of the needle cover 84 prevents the plunger rod 76 from moving until an initial "breakout / breakaway" force is generated, i.e., greater than the normal injection force, to overcome the force between the deflectable arm 83, the proximal end 86 and the plunger rod 76. The "breakout" force can be adjusted as needed for a particular drug product, where the "breakout" force can be a high enough force to prevent the drug product from being discharged too quickly, but low enough so that the user can easily start the injection.
[0094] In some embodiments, the device 80 may include a feedback mechanism. The device 80 may include a visual feedback mechanism, for example, when the plunger rod 76 is fully depressed into the housing 74 ( Figure 7B), the needle cover 84 is fully extended to the distal side of the housing 74, and the needle 96 is covered. In some examples, the device 80 may include an opening for observing the container 92 and the movement of the plunger rod 76 and the stopper 90 in the container 92. The device 80 may also include an audible feedback mechanism, for example, an audible "click" sound once the proximal end of the plunger rod 76 abuts the housing 74 or once the needle cover 84 is pushed away from the housing 74. In some aspects, the device 80 may include tactile feedback, for example, a snap or vibration when the needle cover 84 moves distally and abuts the boss 98 at the end of the injection.
[0095] Figures 14A-14C Another embodiment of the present disclosure is depicted, similar to the above reference Figures 3A-7F Where appropriate, features will be designated with similar reference numerals to those discussed above. Figures 3A-7F Any features and components that correspond to those in the drawings may be understood to be similarly constructed. Fig.14A shows a perspective view of the exterior of the device 140, Fig. 14B An external front view of the device 140 is shown, and Fig. 14C An external side view of the device 140 is shown. The device 140 may include a plunger rod 56, a housing 54, and a needle cover 148. The housing 54 may include a finger flange 142 and a rear cap (rear cover) 144. The finger flange 142 may have any suitable size and / or configuration that allows for proper use. For example, a user may operate the device 140 using two hands. One hand of the user may hold the device 140 while the other hand of the user pushes the plunger rod 56 in a distal direction toward the finger flange 142. As shown in FIG. Figures 14A-14C As shown, the rear cap 144 can include a collar 146. The collar 146 can extend in a proximal direction away from the finger flange 142. The collar 146 can be any suitable size and / or configuration to surround a portion of the plunger rod 56. In some embodiments, the collar 146 can have a generally circular shape.
[0096] Figures 15A-15D A cross-sectional view of the interior of device 140 is depicted. Fig.15A and 15B A cross-sectional view of a quarter portion of the device 140 is depicted. Fig.15A , the device 140 may include a needle cover 64, a syringe 52, a spring shield 53, a needle cap 232, and a needle shield 94. The construction of the needle cap 232 and the needle shield 94 will be discussed in detail herein, for example, with respect to Fig.22A and 22B . refer to Fig. 15B, the device 50 can include various features to couple the finger flange 142 and the rear cap 144 together. For example, the finger flange 142 can include a snap 155, and the rear cap 144 can include an insert 156. The snap 155 and the insert 156 can engage, i.e., snap together, to couple the rear cap 144 to the finger flange 142. The rear cap 144 can also include a rear cap hook 157 for abutting against a boss portion 158 of the housing 14.
[0097] refer to Figures 15B-15D , showing the device 50 in a pre-injection state. The rear cap 144 may include a blocking member 160. The blocking member 160 may correspond to the blocking member 62 described above. The plunger rod 56 may include a recess 170 and may be slidably coupled to the blocking member 62 so that the plunger rod 56 can slide in the distal and proximal directions. The blocking member 62 may include a deflectable arm 63 extending in the distal direction. As shown in FIG. Fig. 15B As shown, the blocking member 62 can include more than one deflectable arm 63. For example, the blocking member 62 can include two, three, four or more deflectable arms 63. In a configuration with more than one deflectable arm 63, the deflectable arms 63 can be equally spaced from each other. For example, if the blocking member 62 includes four deflectable arms 63, each deflectable arm 63 can be approximately 90 degrees from each other.
[0098] In the pre-injection state, one or more deflectable arms 63 may abut a portion of the plunger rod 56. For example, one or more deflectable arms 63 may abut a recess 170 ( Fig. 15B ). The needle cover 64 may include an opening 172 for receiving a portion of one or more deflectable arms 63. In the pre-injection state, the first deflectable arm 63a may abut against the plunger rod 56 so that a portion of the first deflectable arm 63a may fit into the opening 172 ( Fig. 15C The second deflectable arm 63 may abut against the recess 170 ( Fig.15D ). In this initial position, prior to use, the plunger rod 56 can be prevented from significant movement in the proximal or distal directions. For example, if the plunger rod 56 is pushed into the housing 54 in the distal direction, the proximal end 66 of the needle cover 64 prevents the deflectable arm 63a from deflecting outward, thereby locking the deflectable arm 63 within the opening 172 and preventing further movement of the plunger rod 56. If the plunger rod 56 is pulled away from the housing 54 in the proximal direction, the second deflectable arm 63b can be prevented from deflecting outward when it abuts the recess 170.
[0099] To start the injection, the device 140 can be pressed against the injection site to depress the needle cover 64. When the plunger rod 56 is pressed into the housing 54 in the distal direction, the plunger rod 56 can deflect the second deflectable arm 63b of the blocking member 62, thereby allowing the plunger rod 56 to move distally into the syringe 52 so that the injection can be performed. Once the injection is completed, the device 140 can be removed from the injection site and the needle cover 64 can be automatically pulled in the distal direction so that it covers the needle 70 ( Fig. 16B ). In some examples, the spring guard 53 can pull the needle cover 64 in a distal direction. During an injection, when the plunger rod 56 moves distally into the housing 54, the first deflectable arm 63a can deflect inwardly toward the plunger rod 56, thereby allowing the first deflectable arm 63a to disengage from the opening 172. Fig.16A , at the end of the injection, and once the first deflectable arm 63a is located proximal to the needle cover 64, the first deflectable arm 63a can return to the undeflected position and can prevent the needle cover 64 from moving in the proximal direction. The first deflectable arm 63a can now act as a lockout mechanism to prevent reuse of the device 140 or accidental needle sticks, as the needle cover 64 may no longer be able to move distally to expose the needle 70. In this final post-injection position of the device 140, the needle cover 64 can be in a lockout position and the proximal end of the needle cover 64 and the first deflectable arm 63a can abut against each other. At this stage, the device 140 may not be reused.
[0100] Figures 14A-16B Embodiments of the device 140 depicted in the drawings may include one or more additional features, such as, for example, an optimal configuration and sizing of the deflectable arm 62; an ergonomic design to enable two-handed operation, i.e., one hand can hold the syringe at 90 degrees for needle insertion while the second hand pushes the plunger rod 56; an injection complete indicator, such as a visual color change or an audible indicator; an activation point to mitigate potential failure modes, such as a pre-activation point or state; an extension of the plunger rod 56 to seat within the piston of the device to improve alignment of the plunger rod 56 prior to and / or during use; and an optimized design to reduce the required spring force to minimize plastic creep.
[0101] Another embodiment of the present disclosure is shown in Figures 8A-10B middle. Fig. 8A shows an external view of the device 100, and Figure 8B A cross section of the device is shown. The device 100 may be designed to hold any suitable commercially known product container 104 (eg, a syringe or other suitable drug delivery device). Figure 8B , the device 100 may include a housing 106, a needle cover 108, a plunger rod 110, a stopper 112, and a rotating component 114, such as a cam.
[0102] Prior to injection, the needle cover 108 may be extended distally from the housing 106 to cover the needle 118. To initiate an injection, the device 100 may be pressed against an injection site. The device 100 may include a spring (not shown), for example, around the needle cover 108 or at the end of the needle cover 108. For purposes of discussion, the needle cover 108 may be extended distally from the housing 106 to cover the needle 118. Figures 9A-9D An exemplary actuator, such as spring 124, is schematically shown in FIG. Figures 9A-9D The upper region of each of the 2000 and 2001 depicts a cross section of the plunger rod 110 , the rotating component 114 , and the protrusion 116 of the needle cover 108 interacting with the track 120 of the rotating component 114 . Figures 9A-9D The bottom area of each of the figures depicts a side view of the protrusion 116 of the needle cover 108 moving along the track 120 of the rotating member 114, which corresponds to the cross-sectional view of the figure.
[0103] like Figures 9A-9D As shown, the rotating member 114 may include a track 120, i.e., a groove, for receiving the protrusion 116 of the needle cover 108. Fig. 9A ), the actuator 124 can be uncompressed, the needle cover 108 can be extended distally over the needle 118, and the plunger rod 110 can be locked in position relative to the rotating member 114. This can prevent the plunger rod 110 from being pushed distally into the housing 106 until the needle cover 108 is pushed proximally to expose the needle 118. To initiate an injection, the plunger rod 110 can be twisted relative to the rotating member 114, allowing the plunger rod 110 to move from the locked position to the unlocked position. The needle cover 108 can be pushed proximally into the housing 106, for example, by a user pressing the device 100 against an injection site, which can cause the rotating member 114 to rotate and the actuator 124 to compress during an injection ( Fig. 9B ). The plunger rod 110 can be locked in place, i.e., movement of the plunger rod 110 can be prevented until the needle cover 108 is retracted proximally into the housing 106. This configuration can prevent premature expulsion of product. During injection, the needle cover 108 can be held in the retracted position ( ) due to the position of the protrusion 116 on the needle cover 108 in the track 120 of the rotating member 114. Fig. 9B ). This can act as a signal to the user that the device 100 is still in use. In this retracted position, the needle cover 108 can also control the insertion depth of the needle 118, because once the distal end of the needle cover 108 contacts the injection site, the distal end of the needle cover 108 can prevent deeper insertion of the needle 118. Once the injection is completed, the plunger rod 110 can rotate the rotating member 114 to release the needle cover 108 ( Fig. 9C ), and the actuator 124 can push the needle cover 108 downward back to the locked position, wherein the needle cover 108 is removed from the housing 106 ( Fig.9D ) extends distally to cover the needle 118. Fig.9DAs can be seen in the figure, in the locked position, at the end of the injection, the protrusion 116 on the needle cover 108 can engage the notch at the end of the track 120 on the rotating component 114, which prevents the needle cover 108 from being pushed proximally into the housing 106 again to prevent the device 100 from being reused.
[0104] In some embodiments, in the locked position, the needle cover 108 can be pushed out further distally than the initial position of the needle cover 108. For example, Fig. 10A depicts the initial position of the needle cover 108 prior to injection, and Fig. 10B The locked position of the needle cover 108 at the end of the dose is depicted. Portion 122 represents an additional portion of the needle cover 108 that may be exposed at the end of an injection, but not at the beginning of an injection. In some embodiments, the height of the track 120 of the rotating member 114 may be greater at the end point than at the beginning point of the track 120. For example, the beginning point of the track 120 (at Figures 9A-9D 14) may start at the center region of the rotating member 114, may continue to the upper region of the rotating member 114, and then the end point of the track 120 (at Figures 9A-9D The end of the track 120 may be located at a lower region of the rotating member 114. Thus, the height of the end of the track 120 may be greater than the height of the initial portion of the track 120. This increased height at the end of the track 120 may allow the needle cover 108 to extend further outward in its locked position than in its original position ( Fig. 10B ).
[0105] Figures 8A-10B The embodiment depicts a device having a passive safety mechanism that can be activated when the user is nearing the end of the dose (ie, when a large amount of product is completely expelled from the container 104). Figures 8A-10BThe passive safety mechanism of the invention can allow the plunger rod 110 to rotate the rotating component 114 near the end of the dose, which can push the needle cover 108 to the extended locking position proximally. In the locking position, the needle cover 108 does not retract into the housing 106. In such a locking position and before injection, the needle cover 108 can cover the needle 118 to prevent accidental needle sticks after injection. Compared with traditional drug delivery devices with exposed needles, this can also reduce needle phobia and needle-related anxiety. In addition, the needle cover 108 can allow a controlled needle insertion depth. In other words, exposing only a portion of the needle 118 during injection can allow the device 100 to be used without any pre-injection steps (e.g., squeezing the skin to change the injection depth to compensate for the longer needle length compared to the exposed needle 118 of the device 100). The device 100 can be configured such that, for example, the container 104 can be positioned within the housing 106 and / or the needle cover 108 can be sized such that the needle cover 108 exposes only a portion of the needle 118, and the length of the exposed portion of the needle 118 represents a desired insertion depth of the needle 118. As discussed above, during an injection, the needle cover 108 can be maintained in the retracted position ( Fig. 9B ). This prevents the passive safety mechanism from activating before the dose is finished. In addition, if the device 100 is accidentally or intentionally removed from the injection, the passive safety mechanism will not activate because the needle cover 108 is retained in the track 120. Once the device 100 is reapplied to the injection site and the plunger rod 110 is depressed, the injection can be resumed.
[0106] In some embodiments, the device 100 may include a feedback mechanism. The device 100 may include a visual feedback mechanism, such as a plunger rod 110 abutting the housing 106, a needle cover 108 extending completely distally from the housing 106, and / or an extended portion 122 ( Fig. 10B ). In some examples, the needle cover 108 can have a first color, pattern, or texture, for example, and the extension 122 can have a second color, pattern, or texture to show that the device 100 is in a locked position, and that the device has been used and a dose has been expelled. In some examples, the device 100 can include an opening 102 for viewing the container 104 and the movement of the plunger rod 110 and / or the stopper 112 in the container 104. The device 100 can also include an audible feedback mechanism, for example, an audible "click" sound once the plunger rod 110 abuts the housing 106 and / or the needle cover 108 moves distally at the end of the dose. In some aspects, the device 100 can include tactile feedback, for example, a snap or vibration when the needle cover 108 moves distally at the end of an injection.
[0107] The device 100 can have any suitable size and shape to hold or partially hold the container 104, and / or support and hold any of the components described herein. Any component of the device 100 can have a suitable size and / or shape to be configured as and cooperate with other components as designed. For example, the rotating component 114 can have any suitable size and / or shape to be slidably coupled to the plunger rod 110. In another example, the needle cover 108 and / or the protrusion 116 can have any suitable size and / or shape to fit into the track 120 of the rotating component 114.
[0108] Another embodiment of the present disclosure is shown in Figure 11-13B middle. Fig.11 An external view of the device 200 is shown. The device 200 may be designed to hold any suitable commercially available product container 202 (eg, a syringe or other suitable drug delivery device). Fig.11 , the device 200 may include a housing 204, a plunger rod 206, a needle cover 208, and a stopper 230. The proximal region of the housing 204 may include one or more deflectable housing tabs 212. The housing 204 may also include a cap 210 located within the proximal portion of the housing 204. The device 200 may include a locking ring 214 slidably coupled to the proximal end of the container 202. In some embodiments, the housing 204 may include more than one deflectable housing tab 212. For example, the housing 204 may include two, three, four or more deflectable housing tabs 212. In a configuration with more than one deflectable housing tab 212, the deflectable housing tabs 212 may be equally spaced from each other. For example, if the housing 204 includes four deflectable housing tabs 212, each deflectable housing tab 212 may be approximately 90 degrees from each other. If the housing 204 includes two deflectable housing tabs 212 , each of the deflectable housing tabs 212 may be approximately 180 degrees from one another.
[0109] like Fig.11 As shown, the needle cover 208 can be extended and cover the needle 220 before use. Fig. 12A ), the deflectable housing tab 212 can abut a portion of the locking ring 214, and the locking ring 214 can be located proximal to the proximal end 216 of the needle cover 208. The needle cover can be biased in a distal direction (e.g., by a spring), but can be pushed back proximally within the housing 204 for use. To initiate an injection, the needle cover 208 can be pushed into the housing 204 in a proximal direction, for example, by pushing the device 200 to an injection site. When the needle cover 208 moves proximally, the proximal end 216 of the needle cover 208 can hook onto the boss 224 of the locking ring 214 ( Fig. 12B ). The movement of the proximal end 216 of the needle cover 208 relative to the locking ring 214 is Figures 13A-13B 224 . In some examples, the proximal end 216 may include a notch 222 for engaging with a boss 224. In some examples, the needle cover 208 may include more than one notch 222 (e.g., a pair of notches), and the locking ring 214 may include more than one boss 224 (e.g., a pair of bosses). The number of bosses and notches may correspond to each other so that each boss may engage with each notch. Although the locking ring 214 is depicted as including one or more bosses 224, and the proximal end 216 of the needle cover 208 is depicted as including one or more notches 222, the two mating areas may be reversed, i.e., the locking ring 214 may include one or more notches 222, and the needle cover 208 may include one or more bosses 224. In addition, the boss 224 and the notch 222 may represent any suitable mating parts.
[0110] With the needle cover 208 pushed proximally into the housing 204 (eg, by pressing the device 200 against an injection site), the plunger rod 206 may be pushed in a distal direction into the housing 204 to expel product from the container 202 into the injection site.
[0111] Movement of the proximal end 216 of the needle cover 108 into the housing 204 may cause the deflectable tab 212 to flex outwardly away from the plunger rod 206 during an injection, such as Fig. 12B 224, the needle cover 208 and the locking ring 214 can be biased to return downward to their initial position (e.g., via the spring force of a spring guard (not shown) surrounding the needle cover 208). The needle cover 208 and the locking ring 214, which are connected to each other via the cutout 222 and the boss 224, can move downward past the deflectable tab 212, thereby allowing the deflectable tab 212 to flex back to its initial position ( Fig. 12C ).like Fig. 12C As shown, the proximal end of the lockout ring 214 can abut the distal end of the deflectable tab 212. In this final end-of-dose position, the needle cover 208 can be in a lockout position, in which the needle cover 208 can be prevented from moving proximally back into the housing 204 by the deflectable tab 212, which can obstruct the path of the needle cover 208.
[0112] Figure 11-13BThe embodiment of the invention depicts a device with a passive safety mechanism that can be activated at any point when the device 200 is removed from the injection site, regardless of whether the entire dose has been discharged from the container 202. Once the needle cover 208 has been pushed proximally into the housing 204 to start the injection, the passive safety mechanism can be activated. Since the needle cover 208 is biased in the distal direction, the safety mechanism can be activated once the force pushing the needle cover 208 into the housing 204 is removed (e.g., by removing the device 200 from the user's skin). This passive safety mechanism may be helpful for users who may be concerned about needle safety. For example, if the user accidentally drops the device 200 during use, the passive safety mechanism can push the needle cover 208 out to prevent accidental needle sticks. In addition, the needle 220 can be covered by the needle cover 208 and hidden from view before, during, and after the injection. This can reduce needle phobia and needle-related anxiety compared to traditional drug delivery devices with exposed needles. In addition, the needle cover 108 can allow a controlled needle insertion depth. In other words, exposing only a portion of the needle 220 during injection can allow the device 200 to be used without any pre-injection steps (e.g., compressing the skin to change the injection depth to compensate for a longer needle length compared to the exposed needle 220 of the device 200). The device 200 can be configured, for example, the container 202 can be positioned within the housing 204 and / or the size of the needle cover 208 can be designed so that the needle cover 208 only exposes a portion of the needle 220, and the length of the exposed portion of the needle 220 represents the desired insertion depth of the needle 220.
[0113] In some embodiments, the device 200 can include a feedback mechanism. The device 200 can include a visual feedback mechanism, such as a plunger rod 206 abutting the housing 204, a needle cover 208 fully extending distally from the housing 204. In some examples, the device 100 can include an opening for observing the container 202 and the movement of the plunger rod 206 and the stopper 230 in the container 202. The device 200 can also include an audible feedback mechanism, such as once the plunger rod 206 abuts the housing 204, when the needle cover 208 extends distally, and / or when the deflectable tab 212 relaxes back to its initial neutral position ( Fig. 12C ), an audible "click" sound is produced. In some aspects, the device 200 can include tactile feedback, such as a snap or vibration when the needle cover 208 moves distally.
[0114] The device 200 can have any suitable size and shape to hold or partially hold the product container 202, and / or support and hold any of the components described herein. Any component of the device 200 can have a suitable size and / or shape and be configured to cooperate with other components designed. For example, the needle cover 208, the proximal end 216, the cutout 222, the locking ring 214, and the boss 224 can have any suitable size and / or shape that allows the cutout 222 to lock onto the boss 224.
[0115] Fig.22A and Fig. 22B Depicted are embodiments of a needle shield 94 and needle cap 232 that can be used with any of the devices disclosed herein. The needle shield 94 can be attached to a needle cover (not shown) and can extend in a distal direction to completely surround the needle 96. Fig.22A and Fig. 22B As shown, the needle shield 94 can extend in the distal direction so that the needle shield 94 can abut a portion of the needle cap 232. The needle cap 232 may include a clip 221. In other embodiments, the needle cover 232 may include a plurality of clips 221. The shape or configuration of the clip 221 may be designed to attach to the protrusion 223 of the needle shield 94, that is, to latch to the protrusion 223 of the needle shield 94. Fig.22A and 22B The depicted needle cap 232 shows the arms 95 of the needle shield 94. In other embodiments, the needle shield 94 can include multiple arms 95 and gaps between each arm 95. In some examples, the needle cap 232 can include at least two clips, at least three clips, or at least four clips. Fig. 22B , the first clip 221a can be attached to the first boss 223a and abut the first arm 95 of the needle shield 94. The second clip 221b can be attached to the second boss 223b. When the user pulls the needle cap 232 away from the housing 14 in the distal direction, the needle shield 94 can also be removed from the housing 14 at the same time to expose the needle 86.
[0116] Additional concepts and features that may be used with or in any of the devices disclosed herein are discussed below.The following concepts and features may correspond to concepts and features discussed throughout this disclosure.
[0117] Fig.23A and 23B Depicted is a plunger rod 235 that can be used in any of the embodiments discussed herein. The plunger rod 235 can include a first portion 236 and a second portion 237. Fig.23A As shown, the width of the second portion 237 may be smaller than the width of the first portion 236. Fig. 23BWhen the plunger rod 235 moves distally toward the housing 238 to dispense the medicament out of the syringe 12, the second portion 237 can collapse (contract) into the first portion 236, i.e., be inserted into the first portion 236. In other embodiments, the width of the first portion 236 can be less than the width of the second portion 237, so that when the plunger rod 235 moves distally toward the housing 238, the first portion 236 can collapse into the second portion 237. The plunger rod 235 can be referred to as a telescopic plunger rod. Fig.23A and Fig. 23B As shown, when the plunger rod 235 collapses (contracts), the length of the plunger rod 235 changes from a first length ( Fig.23A ) is reduced to a second length (23B).
[0118] Figures 24A-24C An embodiment of the present disclosure is depicted. Device 240 may include thumb pad 241, plunger rod 242, housing 243, syringe 244, spring shroud 245, rotator 246, and needle 249. In the pre-injection state, as shown in FIG. Fig.24A As shown, the rotator 246 can be located proximal to the proximal end of the syringe 244. Fig.24C , the rotator 246 may include an opening 246a, the shape and configuration of which are designed to surround a portion of the plunger rod 242. In some examples, the opening 246a may have a circular shape so that a portion of the plunger rod 242 can slide through the rotator 246 in the distal direction. The rotator 246 may also include a plurality of cutouts 246b. The cutouts 246b may have a shape, size, and configuration corresponding to the proximal end of the syringe 244. For example, the cutouts 246b may correspond to the flange 247 of the syringe 244. In the pre-injection state, the rotator 246 may be located proximal to the proximal end of the syringe 12 so that the cutouts 246b are displaced from the flange 247. The spring guard 245 may surround the proximal end of the syringe 244 so that the syringe 244 may be spring loaded and held below by the rotator 246 ( Fig.24A ). To start the injection, the user may press thumb pad 241 in a distal direction toward housing 243. During injection, as plunger rod 242 moves in a distal direction into housing 243 and syringe 244, plunger rod 242 may rotate such that cutout 246b rotates toward flange 247. At the end of the dose, as shown in FIG. Fig. 24BAs depicted, the syringe 244 can be moved in a proximal direction into the housing 243 and into the rotator 246, and the needle 249 can be contained within the distal end of the housing 243. In some embodiments, the rotator 246 and the syringe 244 can be uncoupled together and can then be moved proximally toward the proximal end of the housing 243. Any suitable syringe 244 can be used with the device 240. For example, the syringe 244 can be a cyclic olefin polymer syringe or a glass cut flange syringe.
[0119] Fig.25 An embodiment of the present disclosure is depicted. Device 250 may include housing 251, syringe 252, and thumb pad 253. Device 250 may also include a telescopic plunger rod including a first portion 254 and a second portion 255. The telescopic plunger rod may correspond to Fig.23A and Fig. 23B The plunger rod 235 is depicted in FIG. Fig.25 As shown, the first portion 254 may include a plurality of bosses 254a, and the second portion 255 may include a plurality of cutouts 255a. The bosses 254a may fit into the cutouts 255a, thereby coupling the first portion 254 to the second portion 255. At the end of the dose, the thumb pad 253 may abut the flange portion 251b of the housing 251. The housing 251 may include a proximal extension 251a. Reference Fig.25 , at the end of the dose, once the thumb pad 253 abuts the flange portion 251b, the first portion 254 and the second portion 255 may also abut the proximal extension 251a. When the first portion 254 and the second portion 255 abut the proximal extension 251a, the boss portion 254a may push the proximal extension 251a, causing the proximal extension 251a to deflect outwardly away from the syringe 252. The spring guard 258 may then pull the syringe 252 and / or the second portion 254 proximally into the thumb pad 253, thereby pulling the needle at the distal end of the syringe (not shown) into the housing 251. In some embodiments, the thumb pad 253 and the housing 251 may include an attachment feature for locking the thumb pad 253 and the housing 251 together at the end of the dose stage.
[0120] Fig.26A and 26B An embodiment of the present disclosure is depicted. Device 260 may include housing 261, syringe 262, and plunger rod 263. Device 260 may also include inner rod 264 extending through plunger rod 263. Fig.26AAs shown, the inner rod 264 can include a button 264a extending proximally from the thumb pad 263a of the plunger rod 263. In the pre-injection state, the deflectable arm 263b of the plunger rod 263 can abut against the distal portion of the inner rod 264, thereby preventing movement of the plunger rod 263 and, therefore, preventing pre-discharge of the contents of the syringe 262. A spring 269 can be included in the plunger rod 263. To start the injection, the user can press the button 264a while pushing the thumb pad 263a in the distal direction toward the housing 261 and against the spring 269. Pressing the button 264a can cause the inner rod 264 to move in the distal direction toward the housing 261. Reference Fig.26B , when the inner rod 264 moves distally into the housing 261, the deflectable arm 263b can then deflect inwardly into the recess 264b. Once the deflectable arm 263b is deflected into the recess 264b, the plunger rod 263 can move freely in the distal direction to dispense the contents of the syringe 262.
[0121] Fig.27A and 27B Depicted with Fig.26A and 26B Device 270 is similar to device 260 in FIG. Device 270 may include housing 271, syringe 272, and plunger rod 273. Device 270 may also include internal rod 274. Fig.27A As shown, the inner rod 274 can include a button 274a extending proximally from the thumb pad 273a of the plunger rod 273. In the pre-injection state, the deflectable arm 273b of the plunger rod 273 can abut against the distal portion of the inner rod 274, thereby preventing movement of the plunger rod 273 and, therefore, preventing pre-discharge of the contents of the syringe 272. A spring 279 can be included in the plunger rod 273. To start the injection, the user can press the button 274a while pushing the thumb pad 273a in the distal direction toward the housing 271 and against the spring 279. Pressing the button 274a can cause the inner rod 274 to move in the distal direction toward the housing 271. Reference Fig.27B , when the inner rod 274 moves distally into the housing 271, the deflectable arm 273b can then deflect inwardly into the recess 274b. Once the deflectable arm 273b is deflected into the recess 274b, the plunger rod 273 can move freely in the distal direction to dispense the contents of the syringe 272.
[0122] Fig.28A and 28B Another embodiment according to the present disclosure is depicted. Device 280 may include housing 281, syringe 282, and plunger rod 283. Fig.28A and 28B As shown, the housing 281 may include a flange 281 a. The housing 281 may also include a trigger 284 . Fig.28A and 28B An internal view of the device 280 is depicted. The trigger 284 can extend through an internal portion of the housing 281, such as the flange 281a. Fig.28A , a portion of the trigger 284 may extend distally from the flange 281a. The flange 281a may include a plurality of slots 284a. The slots 284a may move the trigger 284 within the flange 281a. In the pre-injection state, as Fig.28A As shown, a portion of the trigger 284 abuts against the plunger rod 283, thereby preventing pre-discharge of the contents of the syringe 282. To initiate an injection, the user can push the thumb pad 283a distally toward the housing 281 while squeezing a portion of the trigger 284 that extends distally from the flange 281a. For example, the user can squeeze a portion of the trigger 284 into the flange 281a in the proximal direction. When a portion of the trigger 284 is squeezed, the slot 284a can guide the trigger 284 in a direction away from the plunger rod 283, thereby allowing the plunger rod 283 to move in the distal direction into the housing 281 ( Fig.28B ).
[0123] Fig.29A and 29B Another embodiment according to the present disclosure is depicted. Device 290 may include housing 291, syringe 292, plunger rod 293, and inner rod 294. Figure 2B As shown, the device 290 may include a blocking member 300. The blocking member 300 may correspond to the blocking members 62 and 82 described herein. The blocking member 300 may include a deflectable arm 302. The deflectable arm 302 may correspond to the deflectable arms 63 and 83 as described herein. The internal rod 294 may include a button 294a extending proximally from the thumb pad 293a of the plunger rod 293. The internal rod 294 may also include a distal block 294b. In the pre-injection state, as shown in FIG. Fig.29A As shown, the distal block 294b can be positioned above the spring 295 and within the flexible portion 293b of the plunger rod 293. The distal block 294b can abut against the flexible portion 293b, thereby preventing movement of the deflectable arm 302. This pre-injection state can prevent pre-discharge of the contents from the syringe 292. To start the injection, the user can press the button 294a distally into the plunger rod 293. Pressing the button 294a can cause the inner rod 294 and the distal block 294b to move in the distal direction toward the syringe 292 and against the spring 295. As shown in FIG. Fig.29BAs shown, the distal block 294b can move in the distal direction away from the flexible portion 293b of the plunger rod 293. Then, the deflectable arm 302 can deflect inwardly toward the flexible portion 293b, which can then allow the plunger rod 293 to move distally into the housing 291 and the syringe 292 to expel the contents of the syringe 292.
[0124] Figures 30A-30D Another embodiment according to the present disclosure is depicted. Device 400 may include housing 402, syringe 404, plunger rod 406, rear cap 408, and spring 410 surrounding the proximal portion of syringe 404. Fig. 30A As shown, the proximal portion of the housing 402 may include a plurality of recesses 403a, 403b, and the rear cap 408 may include a plurality of distal arms 409a, 409b. The recesses 403, 403b may be configured to receive the distal arms 409a, 409b. To couple the rear cap 408 to the housing 402, the first distal arm 409a may be hooked into the recess 403a, and the second distal arm 409b may be hooked into the recess 403b. The syringe 404 may also include a syringe flange 405. As shown in FIG. Fig. 30A As shown, the syringe flange 405 can be located between a portion of the finger flange 408 and a portion of the housing 402. For example, the proximal end of the syringe flange 405 can abut the distal inner surface of the finger flange 405, and the distal end of the syringe flange 405 can abut the proximal end of the housing 402. Fig. 30A and 30C , the plunger rod 406 may include a first portion 407a and a second portion 407b. The first portion 407a may have a first diameter, and the second portion 407b may have a second diameter. The first diameter may be greater than the second diameter. In other examples, the first diameter may be less than the second diameter. In some examples, the plunger rod may have a first width and a second width, wherein the first width may be greater than the second width. In other examples, the first width may be less than the second width. Fig. 30C As shown, the plunger rod 406 can include a third portion 407c, wherein the diameter of the third portion 407c is greater than the diameter of the second portion 407b. The finger flange 408 can be any suitable size, shape and / or configuration to surround a portion of the plunger rod 406.
[0125] refer to Fig. 30B , the finger flange 408 may include a first part 412a and a second part 412b. The first part 412a may include a first hook 414a, and the second part 412b may include a second hook 414b. Fig. 30B As shown, the first hook 414a and the second hook 414b can abut and / or surround a portion of the plunger rod 406. In the pre-injection state, as shown in FIG. Fig. 30A and30B As shown, the finger flange 408 can surround the first portion 407a of the plunger rod 406. The finger flange 408 can also include a spring (not shown) configured to separate the first part 412a and the second part 412b ( Fig. 30B ). Movement of the finger flange 408 may be inhibited by the spring and engagement of the first and second hooks 414a, 414b with the first portion 407a of the plunger rod 406. To initiate an injection, the user may press a thumb pad (not shown) of the plunger rod 406 in a distal direction toward the housing 402. During an injection, the plunger rod 406 may be positioned in the housing 402 such that the second portion 407b of the plunger rod 406 is received in the finger flange 408. In embodiments where the diameter of the second portion 407b may be smaller than the diameter of the first portion 407a, the hooks 414a, 414b may no longer abut a portion of the plunger rod 406. For example, as Fig.30D As shown, there may be space between the finger flange 408 and the plunger rod 406, thereby allowing the plunger rod 406 to move distally into the housing 402 and syringe 404 to expel the contents of the syringe 404. At the end of the dose, as shown in FIG. Fig. 30A As shown, the user can maintain compression of the thumb pad, thereby allowing a portion of the plunger rod 406 to retract rearwardly, ie, proximally away from the housing 402. The spring 410 can then be released, thereby allowing the syringe 404 to move proximally toward the distal surface of the finger flange 408.
[0126] Fig.31 and 32A -32F depicts another embodiment according to the present disclosure. Fig.31 The features and mechanisms discussed in and 32a-32F may be utilized and combined with those described above and in Fig. 30A - A combination of features of the device 400 shown in 3D. Fig.31 , Fig.32A , Fig.32B , Fig.32E and Fig.32F A top view of the device 500 is depicted. The device 500 may include a housing (not shown), a finger flange 502, a thumb pad 504, and a slider 506. The thumb pad 504 may include a plurality of clips 508a, 508b. The slider 506 may include an opening 510 for receiving a plunger rod (not shown). The clips 508a, 508b may couple the thumb pad 504 and the plunger rod in the opening 510. The plunger rod utilized in the device 500 and having the various features of the device 500 discussed herein may include various geometric features, such as, for example, Fig.19B The concave portion shown in . Fig.31 , Fig.32A , Fig.32B , Fig.32E and Fig.32F To start the injection, the user can press the plunger rod in the distal direction. During the injection, when the geometry of the plunger rod (e.g., in diameter and / or width) changes, as described above with respect to Figures 30A-30D As described in the device 400 in FIG. 5 , the spring can push the slider 506 (e.g., in the right direction). When the slider 506 is displaced, the inclined surfaces 512a, 512b of the slider 506 can push against the clips 508a, 508b. The inclined surfaces 512a, 512b can have a width greater than the portion of the slider 506 initially located between the clips 508a, 508b. The inclined surfaces 512a, 512b can press against the clips 508a, 508b, causing the clips 508a, 508b to deflect in an outward direction. This unlocks the thumb pad 504 from the plunger rod, while allowing the syringe (not shown) to move in the proximal direction and causing the clips 508a, 508b to deflect in an outward direction to lock into the locked position. Fig.31 is a top view of the device 500 at the end of the dose. Figures 32A-32D A slider 506 including a recess 520 is depicted. The recess 520 may be shaped as a C-block, i.e., have a C-shape. The recess 520 may interact with portions of the housing to prevent the slider and / or the syringe from moving in a proximal direction. These features may eliminate the need for the user to apply additional force at the end of an injection to activate a safety mechanism for locking the syringe. A spring 514 may be located on one side of the slider 506 including the ramps 512a, 512b. The spring 514 may release its stored energy, thereby pushing the syringe in a proximal direction, while the thumb pad 504 and the plunger rod are decoupled from each other.
[0127] The components of device herein can be made of any suitable material, and each component can be made of the same or different material as other components. For example, one or more components can be made of a material comprising a polymer, such as plastic. In some embodiments, one or more components can include a variety of different materials, such as glass, organic glass, any other suitable polymer or copolymer, plastic or rubber. In some embodiments, a part of a product container configured to hold a prepared drug substance can be made of a transparent or translucent material. In some embodiments, the components of device can be made of materials with similar or different hardnesses. In some embodiments, each component can include an elastic material. For example, a deflectable or flexible component can be made of a material with some flexibility, such as to allow deflection. One or more materials listed above (e.g., plastic, rubber, polymer or copolymer) can have such characteristics.
[0128] The above description and examples are illustrative, not restrictive. Without departing from the general scope of the present invention, many modifications and / or changes may be made by those of ordinary skill in the art. For example, and as already referenced, the various aspects of the embodiments described above may be used in any suitable combination with each other. In addition, without departing from the scope of the present invention, parts of the embodiments described above may be removed. In addition, without departing from the scope thereof, modifications may be made to adapt specific situations or aspects to the teachings of various embodiments. Upon reviewing the above description, many other embodiments will also be apparent to those skilled in the art.
[0129] Implementations of the present disclosure may include the following features:
[0130] Item 1. A drug delivery device, comprising: case; a product container disposed in the housing; a plunger rod disposed partially within the product container; and a thumb pad configured to receive a portion of the plunger rod, Wherein the thumb pad and the plunger rod are configured to transition from a first state, wherein in the first state the plunger rod is prevented from moving in a proximal direction, to a second state, wherein in the second state the plunger rod is free to move in a proximal direction.
[0131] Item 2. A device according to Item 1, wherein the thumb pad includes an extension protruding distally from the thumb pad.
[0132] Item 3. The device of Item 2, wherein the housing includes a shoulder, wherein in the first state, the shoulder projects radially inward and prevents movement of the product container.
[0133] Item 4. The device of Item 3, wherein in the second state, the extension of the thumb pad is configured to deflect the shoulder radially outward to allow the product container to move in a proximal direction.
[0134] Item 5. The device of Item 4, wherein the product container and a needle attached to the distal end of the product container are retracted into the housing in the proximal direction such that the needle is located proximal to the distal end of the housing.
[0135] Item 6. The device of Item 5, wherein the distance the product container is proximally retracted into the housing in the second state is substantially equal to the length the needle extends distally from the housing in the first state.
[0136] Item 7. The device of Item 1, wherein the proximal portion of the plunger rod comprises a flange and the thumb pad comprises a recess configured to receive the flange.
[0137] Item 8. The device of Item 1, wherein the plunger rod abuts an inner distal surface of the thumb pad in the second state.
[0138] Item 9. The device of Item 1, wherein audible feedback is generated when a portion of the plunger rod abuts the inner distal surface of the thumb pad in the second state.
[0139] Item 10. The device of Item 1, wherein the housing includes a surface configured to deflect a portion of the thumb pad in an outward direction to release a proximal portion of the plunger rod when transitioning to the second state.
[0140] Item 11. The device of Item 1, wherein the housing includes a cutout configured to engage a portion of the thumb pad to couple the thumb pad to the housing in the second state.
[0141] Item 12. A device according to Item 1, wherein the plunger rod includes a first portion and a second portion, the diameter of the first portion being larger than the diameter of the second portion, so that in a first state, the first portion is close to the second portion, and in a second state, the second portion collapses into the first portion.
[0142] Item 13. The device according to Item 1 further includes a rotator configured to be positioned near a proximal end of the product container in a first state and configured to surround the proximal end of the product container in a second state.
[0143] Item 14. A device according to Item 1, wherein the plunger rod includes a first portion and a second portion, the distal end of the second portion is connected to the proximal end of the first portion, and the shell includes a proximal extension, wherein in a first state, the proximal extension abuts the distal end of the first portion, thereby preventing the product container from moving proximally away from the shell.
[0144] Item 15. The device of Item 14, wherein in a second state, the proximal extension is deflected away from the distal end of the first portion, thereby allowing the product container to move proximally away from the housing and into the thumb pad.
[0145] Item 16. The device of Item 1, wherein the proximal end of the housing includes a rear cap configured to surround the proximal end of the product container.
[0146] Item 17. A drug delivery device, comprising: case; a product container disposed in the housing, and a needle extending from a distal end of the product container; a plunger rod for dispensing product from the product container, the plunger rod comprising a first recess at a distal portion of the plunger rod and a second recess at a proximal portion of the plunger rod; a blocking member at a proximal end of the housing, wherein the plunger rod is slidably received within the blocking member, and wherein the blocking member includes a deflectable arm; and A needle cover is at least partially disposed in the housing.
[0147] Item 18. A device according to Item 17, wherein the device is configured to transition from a first state to a second state and a third state, wherein in the first state the proximal end of the needle cover abuts the deflectable arm and the deflectable arm is aligned with the first recess, wherein in the second state the deflectable arm deflects radially outward, and in the third state the deflectable arm is aligned with the second recess and the proximal end of the needle cover is located distal to the deflectable arm.
[0148] Item 19. A device according to Item 17, wherein the second recess has a smaller diameter than the first recess.
[0149] Item 20. The device of Item 17, wherein the housing includes a boss for abutting a portion of the needle cover to prevent the needle cover from moving proximally into the housing.
[0150] Item 21. The device of Item 18, wherein in the first state, the needle cover extends distally of the housing to cover the needle.
[0151] Item 22. The device according to Item 18, wherein in the second state, the proximal end of the needle cover abuts the distal portion of the blocking member.
[0152] Item 23. The device of Item 18, wherein in the first state, the deflectable arm restricts movement of the plunger rod, and wherein in the second state, the deflected deflectable arm allows movement of the plunger rod.
[0153] Item 24. The device of Item 17, further comprising an inner rod configured to be secured within the plunger rod.
[0154] Item 25. The device of Item 24, wherein the inner rod includes a distal block configured to abut a portion of the plunger rod, thereby preventing the plunger rod from moving in a distal direction.
[0155] Item 26. The device of Item 25, wherein the distal end of the plunger rod comprises a deflectable arm configured to abut against a portion of the inner rod, thereby preventing the plunger rod from moving in a distal direction.
[0156] Item 27. The device of Item 25, wherein the plunger rod includes a flexible segment, such that in a first state, the distal block prevents compression of the flexible segment, and in a second state, the distal block moves away from the flexible segment to allow compression of the flexible segment.
[0157] Item 28. The device of Item 17, wherein the housing includes a finger flange and a button mechanism, wherein the button mechanism is configured to abut a portion of the plunger rod in a first state and deflect away from the plunger rod in a second state.
[0158] Item 29. A drug delivery device, comprising: case; Plunger rod; a needle cover disposed at least partially within the housing; and a rotating component having a track extending along an outer surface of the rotating component, wherein a portion of the plunger rod extends through a central region of the rotating component, wherein the rotating component is located radially inward of a proximal portion of the needle cover, and wherein a protrusion of the needle cover engages the track of the rotating component and is configured to move along the track of the rotating component when the device transitions from a first state to a second state and to a third state.
[0159] Item 30. The apparatus of claim 29, further comprising: Product containers for holding liquid drug products; and A stopper is disposed within the product container, wherein distal movement of the plunger rod moves the stopper distally, and wherein, in the first state, the protrusion engages the first end of the track and distal movement of the plunger rod is restricted.
[0160] Item 31. A device according to Item 30, wherein, in the second state, the protrusion engages the middle portion of the track so as to allow distal movement of the plunger rod and the needle cover is further proximally positioned within the housing relative to the position of the needle cover in the first state.
[0161] Item 32. A device according to Item 31, wherein, in the third state, the protrusion engages the second end of the track and the needle cover is further distally located within the housing relative to the position of the needle cover in the second state to extend from the distal end of the housing.
[0162] Item 33. A device according to Item 32, wherein, in the third state, the needle cover is further distally located within the housing relative to the position of the needle cover in the first state, wherein the needle cover extends from the distal end of the housing in the first state and in the third state.
[0163] Item 34. A drug delivery device, comprising: a housing including a deflectable tab; a syringe disposed in the housing; a plunger rod comprising a stopper for dispensing a product contained in said syringe; a needle cover at least partially disposed in the housing, the needle cover comprising a recess; and a ring including a boss portion, the ring being positioned around the proximal end of the syringe, The device is configured to transition between a first state, a second state, and a third state, wherein, in the second state, the needle cover is further proximally located within the housing than in the first state and the third state, the proximal end of the needle cover is configured to push the deflectable tab of the housing outwardly, and the recess of the needle cover engages the boss portion of the ring.
[0164] Item 35. The device of Item 34, wherein in the third state, the needle cover and the ring are located distal to the deflectable tab, and the deflectable tab limits movement of the needle cover in the proximal direction.
[0165] Item 36. A device according to Item 35, wherein in the first state, the needle cover is located distal to the ring.
[0166] Item 37. A drug delivery device, comprising: case; a product container disposed in the housing; and a plunger rod partially disposed within the product container, the plunger rod comprising a first portion and a second portion, wherein the first portion is configured to receive the second portion, The first and second portions of the plunger rod are configured to transition from a first state, wherein in the first state the second portion of the plunger rod is prevented from moving in a proximal direction, to a second state, wherein in the second state the second portion of the plunger rod is free to move in a proximal direction.
[0167] Item 38. A device according to Item 37, wherein the first portion includes a thumb pad.
[0168] Item 39. The device of Item 38, wherein the thumb pad includes a recess configured to receive the second portion of the plunger rod.
[0169] Item 40. The device of Item 37, wherein in the second state, the second portion of the plunger rod moves in a proximal direction into the first portion of the plunger rod.
[0170] Item 41. The device of Item 37, wherein the plunger rod comprises a flexible portion.
[0171] Item 42. The device of Item 37, wherein the second portion of the plunger rod is removably coupled to the first portion of the plunger rod.
Claims
1. A drug delivery device, comprising: case; a product container disposed in the housing; a plunger rod disposed partially within the interior of the product container; as well as a thumb pad configured to receive a portion of the plunger rod, Wherein the thumb pad and the plunger rod are configured to transition from a first state, wherein in the first state the plunger rod is prevented from moving in a proximal direction, to a second state, wherein in the second state the plunger rod is free to move in a proximal direction.
2. The device of claim 1, wherein the thumb pad includes an extension protruding distally from the thumb pad.
3. The device of claim 2, wherein the housing includes a shoulder, wherein in the first state, the shoulder projects radially inwardly and prevents movement of the product container.
4. The device of claim 3, wherein in the second state, the extension of the thumb pad is configured to deflect the shoulder radially outward to allow the product container to move in a proximal direction.
5. The device of claim 4, wherein the product container and a needle attached to the distal end of the product container are retracted into the housing in the proximal direction such that the needle is located proximal to the distal end of the housing.
6. The device of claim 5, wherein the distance the product container is proximally retracted into the housing in the second state is substantially equal to the length the needle extends distally from the housing in the first state.
7. The device of claim 1, wherein the proximal portion of the plunger rod includes a flange, and the thumb pad includes a recess configured to receive the flange.
8. The device of claim 1, wherein the plunger rod abuts an inner distal surface of the thumb pad in the second state.
9. The device of claim 1, wherein audible feedback is generated when a portion of the plunger rod abuts an inner distal surface of the thumb pad in the second state.
10. The device of claim 1, wherein the housing includes a surface configured to deflect a portion of the thumb pad in an outward direction to release a proximal portion of the plunger rod when transitioning to the second state.
11. The device of claim 1, wherein the housing includes a cutout configured to engage a portion of the thumb pad to couple the thumb pad to the housing in the second state.
12. The device of claim 1, wherein the plunger rod comprises a first portion and a second portion, the first portion having a diameter greater than a diameter of the second portion such that in a first state, the first portion is proximal to the second portion, and in a second state, the second portion is retracted into the first portion.
13. The device of claim 1, further comprising a rotator configured to be located proximal to a proximal end of the product container in a first state and configured to surround the proximal end of the product container in a second state.
14. The device of claim 1 , wherein the plunger rod comprises a first portion and a second portion, a distal end of the second portion being coupled to a proximal end of the first portion, and the housing comprises a proximal extension, wherein in a first state, the proximal extension abuts the distal end of the first portion, thereby preventing the product container from moving proximally away from the housing.
15. The device of claim 14, wherein in a second state, the proximal extension is deflected away from the distal end of the first portion, thereby allowing the product container to move proximally away from the housing and into the thumb pad.
16. The device of claim 1, wherein the proximal end of the housing includes a rear cap configured to surround the proximal end of the product container.
17. A drug delivery device, comprising: case; a product container disposed in the housing, and a needle extending from a distal end of the product container; a plunger rod for dispensing product from the product container, the plunger rod comprising a first recess at a distal portion of the plunger rod and a second recess at a proximal portion of the plunger rod; a blocking member at a proximal end of the housing, wherein the plunger rod is slidably received within the blocking member, and wherein the blocking member includes a deflectable arm; and A needle cover is at least partially disposed in the housing.
18. A device according to claim 17, wherein the device is configured to transition from a first state to a second state and a third state, in which the proximal end of the needle cover abuts the deflectable arm and the deflectable arm is aligned with the first recess, in which the deflectable arm is radially deflected outward, and in which the proximal end of the needle cover is located distally of the deflectable arm.
19. The device of claim 17, wherein the second recess has a smaller diameter than the first recess.
20. The device of claim 17, wherein the housing includes a boss for abutting a portion of the needle cover to prevent proximal movement of the needle cover into the housing.
21. The device of claim 18, wherein in the first state, the needle cover extends distally of the housing to cover the needle.
22. The device of claim 18, wherein in the second state, the proximal end of the needle cover abuts a distal portion of the blocking member.
23. The device of claim 18, wherein in the first state, the deflectable arm restricts movement of the plunger rod, and wherein in the second state, the deflected deflectable arm permits movement of the plunger rod.
24. The device of claim 17, further comprising an inner rod configured to be secured within the plunger rod.
25. The device of claim 24, wherein the inner rod includes a distal block configured to abut a portion of the plunger rod to prevent movement of the plunger rod in a distal direction.
26. The device of claim 25, wherein the distal end of the plunger rod comprises a deflectable arm configured to abut against a portion of the inner rod, thereby preventing the plunger rod from moving in a distal direction.
27. The device of claim 25, wherein the plunger rod includes a flexible section, such that in a first state, the distal block prevents the flexible section from compressing, and in a second state, the distal block moves away from the flexible section to allow the flexible section to compress.
28. The device of claim 17, wherein the housing comprises a finger flange and a button mechanism, wherein the button mechanism is configured to abut a portion of the plunger rod in a first state and deflect away from the plunger rod in a second state.
29. A drug delivery device, the device comprising: case; Plunger rod; a needle cover disposed at least partially within the housing; and a rotating member having a track extending along an outer surface of the rotating member, wherein a portion of the plunger rod extends through a central region of the rotatable component, wherein the rotatable component is located radially inward of a proximal portion of the needle cover, and wherein a protrusion of the needle cover engages the track of the rotatable component and is configured to move along the track of the rotatable component as the device transitions from the first state to the second state and to the third state.
30. The apparatus of claim 29, further comprising: Product containers for holding liquid drug products; and a stopper disposed within the product container, wherein distal movement of the plunger rod causes the stopper to move distally, and in, In the first state, the protrusion engages the first end of the track and distal movement of the plunger rod is restricted.
31. The device according to claim 30, wherein In the second state, the protrusion engages the intermediate portion of the track such that distal movement of the plunger rod is permitted and the needle cover is positioned further proximally within the housing relative to its position in the first state.
32. The device according to claim 31, wherein In the third state, the protrusion engages the second end of the track and the needle cover is located further distally within the housing relative to its position in the second state to extend from the distal end of the housing.
33. The device according to claim 32, wherein: In the third state, the needle cover is located further distally within the housing relative to its position in the first state, wherein the needle cover extends from the distal end of the housing in the first state and in the third state.
34. A drug delivery device, the device comprising: a housing including a deflectable tab; a syringe disposed in the housing; a plunger rod comprising a stopper for dispensing a product contained in said syringe; a needle cover at least partially disposed in the housing, the needle cover comprising a recess; and a ring including a boss portion, the ring being positioned around the proximal end of the syringe, wherein the device is configured to transition between a first state, a second state, and a third state, Wherein, in the second state, the needle cover is further proximally located within the housing compared to the first state and the third state, the proximal end of the needle cover is configured to push the deflectable tab of the housing outward, and the recess of the needle cover engages with the boss portion of the ring.
35. The device according to claim 34, wherein In the third state, the needle cover and the ring are located distally of the deflectable tab, and the deflectable tab limits movement of the needle cover in the proximal direction.
36. The device of claim 35, wherein in the first state, the needle cover is located distally of the ring.
37. A drug delivery device, the device comprising: case; a product container disposed in the housing; and a plunger rod partially disposed within the product container, the plunger rod comprising a first portion and a second portion, wherein the first portion is configured to receive the second portion, The first and second portions of the plunger rod are configured to transition from a first state, wherein in the first state the second portion of the plunger rod is prevented from moving in a proximal direction, to a second state, wherein in the second state the second portion of the plunger rod is free to move in a proximal direction.
38. The device of claim 37, wherein the first portion comprises a thumb pad.
39. The device of claim 38, wherein the thumb pad includes a recess configured to receive the second portion of the plunger rod.
40. The device of claim 37, wherein in the second state, the second portion of the plunger rod moves in a proximal direction into the first portion of the plunger rod.
41. The device of claim 37, wherein the plunger rod comprises a flexible portion.
42. The device of claim 37, wherein the second portion of the plunger rod is removably coupled to the first portion of the plunger rod.
